<PAGE>
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): NOVEMBER 9, 1995
------------------------
HORIZON/CMS HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
------------------------
<TABLE>
<S> <C> <C>
DELAWARE 1-9369 91-1346899
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
</TABLE>
<TABLE>
<S> <C>
6001 INDIAN SCHOOL ROAD, N.E.
SUITE 530
ALBUQUERQUE, NM 87110
(Address of principal executive offices) (Zip Code)
</TABLE>
Registrant's telephone number, including area code: (505) 881-4961
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
ITEM 5. OTHER EVENTS.
On November 9, 1995, Horizon/CMS Healthcare Corporation ("Horizon") entered
into (i) the Agreement and Plan of Merger, dated as of November 9, 1995, (the
"Merger Agreement") by and among Horizon, Horizon PRSM Corporation, a wholly
owned subsidiary of Horizon ("Merger Sub"), and Pacific Rehabilitation & Sports
Medicine, Inc. ("Pacific Rehab"); (ii) the Stock Option Agreement, dated as of
March 31, 1995, by and among Horizon and Pacific Rehab (the "Stock Option
Agreement"); and (iii) the Voting Agreement, dated as of March 31, 1995, between
Horizon and certain stockholders of Pacific Rehab named therein (the "Voting
Agreement"). The Merger Agreement, the Stock Option Agreement, the Voting
Agreement and the joint press release of Horizon and Pacific Rehab, dated
November 9, 1995 (the "Joint Press Release"), are filed as Exhibits 2.1, 2.2,
2.3 and 99 hereto, respectively, and are specifically incorporated herein by
reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
<TABLE>
<S> <C>
2.1 Agreement and Plan of Merger, dated as of November 9, 1995, by and among Horizon,
Merger Sub and Pacific Rehab.
2.2 Stock Option Agreement, dated as of November 9, 1995, by and among Horizon and
Pacific Rehab.
2.3 Voting Agreement, dated as of November 9, 1995, between Horizon and the stockholders
of Pacific Rehab named therein.
99 Joint Press Release.
</TABLE>
1
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
to the undersigned, thereunto duly authorized.
Date: November 20, 1995
HORIZON/CMS HEALTHCARE CORPORATION
By: ______/s/_Ernest A. Schofield_____
Ernest A. Schofield
Senior Vice President and
Chief Financial Officer
2
<PAGE>
EXHIBIT INDEX
<TABLE>
<CAPTION>
EXHIBIT SEQUENTIAL
NUMBER DESCRIPTION OF EVENTS PAGE NUMBER
- --------- ----------------------------------------------------------------------------------------- ---------------
<S> <C> <C>
2.1 Agreement and Plan of Merger, dated as of November 9, 1995, by and among Horizon/CMS
Healthcare Corporation, Horizon PRSM Corporation and Pacific Rehabilitation & Sports
Medicine, Inc.
2.2 Stock Option Agreement, dated as of November 9, 1995, by and among Horizon/CMS Healthcare
Corporation and Pacific Rehabilitation & Sports Medicine, Inc.
2.3 Voting Agreement, dated as of March 31, 1995, between Horizon/CMS Healthcare Corporation
and the stockholders of Pacific Rehabilitation & Sports Medicine, Inc. named therein.
99 Joint Press Release of Horizon/CMS Healthcare Corporation and Pacific Rehabilitation &
Sports Medicine, Inc., dated March 31, 1995.
</TABLE>
<PAGE>
EXHIBIT 2.1
=============================================================================
AGREEMENT AND PLAN OF MERGER
among
HORIZON/CMS HEALTHCARE CORPORATION,
HORIZON PRSM CORPORATION,
and
PACIFIC REHABILITATION & SPORTS MEDICINE, INC.
Dated as of November 9, 1995
=============================================================================
<PAGE>
TABLE OF CONTENTS
ARTICLE I
THE MERGER
1.1 THE MERGER. . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 CLOSING . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.3 EFFECTIVE TIME. . . . . . . . . . . . . . . . . . . . . . 2
1.4 EFFECT OF THE MERGER. . . . . . . . . . . . . . . . . . . 2
1.5 CERTIFICATE OF INCORPORATION AND BYLAWS . . . . . . . . . 2
1.6 DIRECTORS AND OFFICERS. . . . . . . . . . . . . . . . . . 2
1.7 CONSIDERATION; CONVERSION OF SECURITIES . . . . . . . . . 2
1.8 EXCHANGE OF CERTIFICATES. . . . . . . . . . . . . . . . . 3
1.9 STOCK TRANSFER BOOKS. . . . . . . . . . . . . . . . . . . 5
1.10 COMPANY STOCK OPTIONS AND PLANS . . . . . . . . . . . . . 5
1.11 OTHER OUTSTANDING RIGHTS TO ACQUIRE OR RECEIVE COMPANY
COMMON STOCK. . . . . . . . . . . . . . . . . . . . . . . 7
ARTICLE II
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
2.1 ORGANIZATION AND QUALIFICATION. . . . . . . . . . . . . . 7
2.2 CAPITALIZATION OF THE COMPANY . . . . . . . . . . . . . . 8
2.3 AUTHORIZATION AND VALIDITY OF AGREEMENT . . . . . . . . . 8
2.4 CONSENTS AND APPROVALS. . . . . . . . . . . . . . . . . . 8
2.5 NO VIOLATION. . . . . . . . . . . . . . . . . . . . . . . 9
2.6 SEC REPORTS; FINANCIAL STATEMENTS . . . . . . . . . . . . 9
2.7 FORM S-4 AND PROXY STATEMENT. . . . . . . . . . . . . . . 10
2.8 COMPLIANCE WITH LAW . . . . . . . . . . . . . . . . . . . 10
2.9 ABSENCE OF CERTAIN CHANGES. . . . . . . . . . . . . . . . 11
2.10 LITIGATION. . . . . . . . . . . . . . . . . . . . . . . . 11
2.11 EMPLOYEE BENEFIT MATTERS. . . . . . . . . . . . . . . . . 11
2.12 TAXES . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.13 INSURANCE . . . . . . . . . . . . . . . . . . . . . . . . 12
2.14 EMPLOYMENT AGREEMENTS . . . . . . . . . . . . . . . . . . 12
2.15 BROKERS AND FINDERS . . . . . . . . . . . . . . . . . . . 12
2.16 OPINION OF FINANCIAL ADVISOR. . . . . . . . . . . . . . . 12
2.17 TAX MATTERS; POOLING. . . . . . . . . . . . . . . . . . . 12
2.18 AFFILIATES. . . . . . . . . . . . . . . . . . . . . . . . 13
2.19 CERTAIN BUSINESS PRACTICES. . . . . . . . . . . . . . . . 13
2.20 PERMITS; COMPLIANCE . . . . . . . . . . . . . . . . . . . 13
<PAGE>
ARTICLE III
REPRESENTATIONS AND WARRANTIES
OF PARENT AND MERGER SUB
3.1 ORGANIZATION AND QUALIFICATION. . . . . . . . . . . . . . 15
3.2 CAPITALIZATION OF THE PARENT AND MERGER SUB . . . . . . . 15
3.3 AUTHORIZATION AND VALIDITY OF AGREEMENT . . . . . . . . . 16
3.4 CONSENTS AND APPROVALS. . . . . . . . . . . . . . . . . . 16
3.5 NO VIOLATION. . . . . . . . . . . . . . . . . . . . . . . 16
3.6 COMPLIANCE WITH LAW . . . . . . . . . . . . . . . . . . . 17
3.7 ABSENCE OF CERTAIN CHANGES. . . . . . . . . . . . . . . . 17
3.8 EMPLOYEE BENEFIT MATTERS. . . . . . . . . . . . . . . . . 17
3.9 TAXES . . . . . . . . . . . . . . . . . . . . . . . . . . 18
3.10 INSURANCE . . . . . . . . . . . . . . . . . . . . . . . . 18
3.11 EMPLOYMENT AGREEMENTS . . . . . . . . . . . . . . . . . . 18
3.12 LITIGATION. . . . . . . . . . . . . . . . . . . . . . . . 18
3.13 SUFFICIENT FUNDS. . . . . . . . . . . . . . . . . . . . . 19
3.14 OPERATIONS OF MERGER SUB. . . . . . . . . . . . . . . . . 19
3.15 SEC REPORTS AND FINANCIAL STATEMENTS; ABSENCE OF
UNDISCLOSED LIABILITIES . . . . . . . . . . . . . . . . . 19
3.16 FORM S-4 AND PROXY STATEMENT. . . . . . . . . . . . . . . 20
3.17 BROKERS AND FINDERS . . . . . . . . . . . . . . . . . . . 20
3.18 TAX MATTERS; POOLING. . . . . . . . . . . . . . . . . . . 20
3.19 AFFILIATES. . . . . . . . . . . . . . . . . . . . . . . . 20
3.20 CERTAIN BUSINESS PRACTICES. . . . . . . . . . . . . . . . 20
3.21 PERMITS; COMPLIANCE . . . . . . . . . . . . . . . . . . . 21
ARTICLE IV
COVENANTS
4.1 CONDUCT OF BUSINESS PENDING THE MERGER. . . . . . . . . . 22
4.2 ACCESS; CONFIDENTIALITY . . . . . . . . . . . . . . . . . 24
4.3 FURTHER ACTIONS . . . . . . . . . . . . . . . . . . . . . 24
4.4 NOTICE OF CERTAIN MATTERS . . . . . . . . . . . . . . . . 24
4.5 FORM S-4, PROXY STATEMENT AND OTHER FILINGS.. . . . . . . 25
4.6 POOLING AND TAX-FREE REORGANIZATION TREATMENT . . . . . . 25
4.7 AFFILIATE AGREEMENTS. . . . . . . . . . . . . . . . . . . 25
4.8 COMPANY'S STOCKHOLDERS' MEETING . . . . . . . . . . . . . 26
4.9 COOPERATION . . . . . . . . . . . . . . . . . . . . . . . 26
4.10 PUBLIC ANNOUNCEMENTS. . . . . . . . . . . . . . . . . . . 27
4.11 ACQUISITION PROPOSALS . . . . . . . . . . . . . . . . . . 27
4.12 D&O INDEMNIFICATION AND INSURANCE . . . . . . . . . . . . 28
4.13 THE COMPANY'S PLANS . . . . . . . . . . . . . . . . . . . 29
<PAGE>
ARTICLE V
CLOSING CONDITIONS
5.1 CONDITIONS TO OBLIGATIONS OF EACH PARTY TO EFFECT THE
MERGER. . . . . . . . . . . . . . . . . . . . . . . . . . 30
5.2 CONDITIONS PRECEDENT TO THE OBLIGATIONS OF THE
COMPANY . . . . . . . . . . . . . . . . . . . . . . . . . 31
5.3 CONDITIONS PRECEDENT TO THE OBLIGATIONS OF PARENT AND
MERGER SUB. . . . . . . . . . . . . . . . . . . . . . . . 31
ARTICLE VI
TERMINATION
6.1 TERMINATION . . . . . . . . . . . . . . . . . . . . . . . 32
6.2 EFFECT OF TERMINATION . . . . . . . . . . . . . . . . . . 33
6.3 FEES, EXPENSES AND OTHER PAYMENTS . . . . . . . . . . . . 33
ARTICLE VII
MISCELLANEOUS
7.1 NO SURVIVAL . . . . . . . . . . . . . . . . . . . . . . . 34
7.2 NOTICES . . . . . . . . . . . . . . . . . . . . . . . . . 35
7.3 CERTAIN DEFINITIONS . . . . . . . . . . . . . . . . . . . 36
7.4 ENTIRE AGREEMENT. . . . . . . . . . . . . . . . . . . . . 36
7.5 ASSIGNMENT; BINDING EFFECT. . . . . . . . . . . . . . . . 36
7.6 AMENDMENTS. . . . . . . . . . . . . . . . . . . . . . . . 37
7.7 WAIVERS . . . . . . . . . . . . . . . . . . . . . . . . . 37
7.8 CAPTIONS. . . . . . . . . . . . . . . . . . . . . . . . . 37
7.9 COUNTERPARTS. . . . . . . . . . . . . . . . . . . . . . . 37
7.10 GOVERNING LAW . . . . . . . . . . . . . . . . . . . . . . 38
<PAGE>
AGREEMENT AND PLAN OF MERGER
AGREEMENT AND PLAN OF MERGER dated as of ___________________ ,
1995 by and among PACIFIC REHABILITATION & SPORTS MEDICINE, INC., a Delaware
corporation (the "COMPANY"), HORIZON/CMS HEALTHCARE CORPORATION, a Delaware
corporation ("PARENT"), and HORIZON PRSM CORPORATION, a Delaware corporation
("MERGER SUB").
RECITALS
WHEREAS, the Boards of Directors of the Company, Parent and
Merger Sub each have determined that it is advisable and in the best
interests of their respective stockholders for Merger Sub to merge with and
into the Company, upon the terms and subject to the conditions of this
Agreement;
WHEREAS, for federal income tax purposes, it is intended that the
Merger (as defined in Section 1.1) shall qualify as a reorganization within
the meaning of Section 368(a) of the Internal Revenue Code of 1986, as
amended;
WHEREAS, for accounting purposes, it is intended that the Merger
shall be accounted for as a "pooling of interests"; and
WHEREAS, the Company, Parent and Merger Sub desire to make
certain representations, warranties, covenants and agreements in connection
with this Agreement.
NOW, THEREFORE, in consideration of the foregoing and of the
respective representations, warranties, covenants and agreements set forth in
this Agreement, the parties hereto hereby agree as follows:
ARTICLE I
THE MERGER
1.1 THE MERGER. Upon the terms and subject to the conditions
of this Agreement, and in accordance with the General Corporation Law of the
State of Delaware (the "DGCL"), at the Effective Time (as defined below),
Merger Sub shall be merged with and into the Company (the "MERGER"). As a
result of the Merger, the separate corporate existence of Merger Sub shall
cease, and the Company shall continue as the surviving corporation of the
Merger (the "SURVIVING CORPORATION").
1.2 CLOSING. Unless this Agreement shall have been terminated
pursuant to Article VI and subject to the satisfaction or, if permissible,
waiver of the conditions set forth in Article V, the consummation of the
Merger and the other transactions contemplated hereby (the "CLOSING") shall
take place at the offices of Garvey, Schubert & Barer, 11th Floor, 121 S.W.
Morrison Street, Portland, Oregon 97204, as promptly as
<PAGE>
practicable (and in any event within two business days) following the
satisfaction or, if permissible, waiver of the conditions set forth in
Article V, unless another place, date or time is agreed to in writing by
Parent and the Company.
1.3 EFFECTIVE TIME. As promptly as practicable after the
satisfaction or, if permissible, waiver of the conditions set forth in
Article V, the parties hereto will cause a certificate of merger (the
"CERTIFICATE OF MERGER") to be executed, verified and filed with the Delaware
Secretary of State in accordance with the DGCL. The Merger shall become
effective at such time as the Certificate of Merger is filed with the
Delaware Secretary of State in accordance with the DGCL, or at such later
time as may be agreed to by Parent and the Company and specified in the
Certificate of Merger in accordance with applicable law. The date and time
when the Merger shall become effective is referred to herein as the
"EFFECTIVE TIME".
1.4 EFFECT OF THE MERGER. The Merger shall have the effects
set forth in the DGCL. Without limiting the generality of the foregoing, and
subject thereto, at the Effective Time, all properties, rights, privileges,
powers and franchises of the Company and Merger Sub shall vest in the
Surviving Corporation, and all debts, liabilities and duties of the Company
and Merger Sub shall become the debts, liabilities and duties of the
Surviving Corporation.
1.5 CERTIFICATE OF INCORPORATION AND BYLAWS. At the Effective
Time, the Amended and Restated Certificate of Incorporation and the Amended
and Restated Bylaws of the Company, as in effect immediately prior to the
Effective Time, shall be the Certificate of Incorporation and the Bylaws of
the Surviving Corporation.
1.6 DIRECTORS AND OFFICERS. At the Effective Time, the
officers and directors of Merger Sub immediately prior to the Effective Time
shall become the officers and directors of the Surviving Corporation, each to
hold office from the Effective Time until their respective successors are
duly elected or appointed and qualified in the manner provided in the
Certificate of Incorporation and Bylaws of the Surviving Corporation and
applicable law. The Company shall use commercially reasonable efforts to
cause each officer and director of the Company to tender his or her
resignation immediately prior to the Effective Time.
1.7 CONSIDERATION; CONVERSION OF SECURITIES. At the Effective
Time, by virtue of the Merger and without any action on the part of any of
the parties hereto or the holders of any of the following securities:
(a) Each share of common stock, par value $.01 per share,
of the Company ("COMPANY COMMON STOCK") which is issued and
outstanding immediately prior to the Effective Time (other than
any shares of Company Common Stock to be cancelled pursuant to
Section 1.7(b)) shall be changed and converted into and represent
the right to .3483 shares of common stock, par value $.001 per
share, of the Parent ("PARENT COMMON STOCK") (the "COMMON STOCK
EXCHANGE RATIO"). All such shares of Company Common Stock shall
no longer be outstanding and shall automatically be cancelled and
extinguished and shall cease to exist, and each certificate which
immediately prior to the Effective Time evidenced any such shares
shall thereafter
<PAGE>
represent the right to receive (without interest), upon surrender
of such certificate in accordance with the provisions of Section
1.8, that number of shares of Parent Common Stock determined
pursuant to the Common Stock Exchange Ratio (the "MERGER
CONSIDERATION"). The holders of certificates previously
evidencing shares of Company Common Stock outstanding immediately
prior to the Effective Time shall cease to have any rights with
respect thereto (including, without limitation, any rights to vote
or to receive dividends and distributions in respect of such
shares), except as otherwise provided herein or by law.
(b) All shares of Company Common Stock, which immediately
prior to the Effective Time are owned of record by Parent or any
of Parent's affiliates (other than natural persons), shall remain
outstanding and shall not be cancelled or converted into any
consideration by reason of the Merger and shall continue as shares
of the capital stock of the Surviving Corporation, and each
certificate evidencing ownership of any such shares shall continue
to evidence ownership of the same number and kind of shares of the
Surviving Corporation. All shares of Company Common Stock held by
the Company in its treasury shall be cancelled and extinguished
and shall cease to exist and no consideration shall be delivered
with respect thereto.
(c) Each share of capital stock of Merger Sub issued and
outstanding immediately prior to the Effective Time shall be
converted into and exchanged for one validly issued, fully paid
and nonassessable share of common stock of the Surviving
Corporation.
(d) In the event of any reclassification, stock split or
stock dividend with respect to Parent Common Stock, any change or
conversion of Parent Common Stock into other securities, or any
other dividend or distribution with respect to Parent Common Stock
prior to the Effective Time, appropriate and proportionate
adjustment, if any, shall be made to the Merger Consideration and
all references to Merger Consideration in this Agreement shall be
deemed to be the Merger Consideration as so adjusted.
1.8 EXCHANGE OF CERTIFICATES.
(a) EXCHANGE AGENT. As of the Effective Time, Parent shall,
pursuant to an agreement with Chemical Mellon Shareholder Services (the
"EXCHANGE AGENT"), deposit, or cause to be deposited, with or for the account
of the Exchange Agent in trust for the benefit of the holders of shares of
Company Common Stock for exchange through the Exchange Agent in accordance
with this Article I, certificates representing shares of Parent Common Stock
in the aggregate number required to be exchanged for shares of Company Common
Stock pursuant to Section 1.7, together with cash payable in respect of
fractional shares (the "EXCHANGE FUND"). The Exchange Agent shall, pursuant
to irrevocable instructions, deliver certificates representing shares of
Parent Common Stock (together with cash payable in respect of fractional
shares) out of the Exchange Fund to holders of shares of Company Common
Stock. The Exchange Fund shall not be used for any other purpose.
<PAGE>
(b) EXCHANGE PROCEDURE. Promptly after the Effective Time,
Parent will cause the Exchange Agent to mail to each holder of record of a
certificate or certificates which immediately prior to the Effective Time
evidenced outstanding shares of Company Common Stock ("CERTIFICATES"), (i) a
notice of the effectiveness of the Merger; (ii) a letter of transmittal
(which shall specify that delivery shall be effected, and risk of loss and
title to the Certificates shall pass, only upon delivery of the Certificates
to the Exchange Agent and shall be in such customary form and have such other
provisions as Parent may reasonably specify in accordance with the terms of
this Agreement); and (iii) instructions to effect the surrender of the
Certificates in exchange for certificates representing shares of Parent
Common Stock. Upon surrender of a Certificate for cancellation to the
Exchange Agent together with such letter of transmittal, duly executed, and
such other customary documents as may be required pursuant to such
instructions, the holder of such Certificate shall be entitled to receive in
exchange therefor a certificate representing that number of whole shares of
Parent Common Stock and, if applicable, a check representing the cash
consideration to which such holder may be entitled on account of a fractional
share of Parent Common Stock, which such holder has the right to receive
pursuant to the provisions of this Article I, and the Certificate so
surrendered shall forthwith be cancelled. In the event of a transfer of
ownership of shares of Company Common Stock which is not registered in the
transfer records of the Company, a certificate representing that number of
whole shares of Parent Common Stock and, if applicable, a check representing
the cash consideration to which such holder may be entitled on account of a
fractional share of Parent Common Stock, which such holder has the right to
receive pursuant to the provisions of this Article I, may be paid or issued
to the transferee if the Certificate representing such Company Common Stock
is presented to the Exchange Agent, accompanied by all documents required to
evidence and effect such transfer and by evidence that any applicable stock
transfer taxes have been paid. In the event that any certificate for Company
Common Stock shall have been lost, stolen or destroyed, the Exchange Agent
shall issue in exchange therefor, upon the making of an affidavit of that
fact by the holder thereof and such bond, security, or indemnity as Parent
may reasonably require, a certificate representing that number of whole
shares of Parent Common Stock and, if applicable, a check representing the
cash consideration to which such holder may be entitled on account of a
fractional share of Parent Common Stock, which such holder has the right to
receive pursuant to the provisions of this Article I. Until surrendered as
contemplated by this Section 1.8, each Certificate shall be deemed at any
time after the Effective Time to evidence only the right to receive upon such
surrender a certificate representing that number of whole shares of Parent
Common Stock and, if applicable, a check representing the cash consideration
to which such holder may be entitled on account of a fractional share of
Parent Common Stock, which such holder has the right to receive pursuant to
the provisions of this Article I.
(c) DISTRIBUTIONS WITH RESPECT TO UNEXCHANGED SHARES. No
dividends or other distributions declared or made after the Effective Time
with respect to Parent Common Stock with a record date after the Effective
Time shall be paid to any holder of any unsurrendered Certificate with
respect to the shares of Parent Common Stock represented thereby and no cash
payment in lieu of fractional shares shall be paid to any such holder until
the holder of record of such Certificate shall surrender such Certificate.
Subject to the effect of applicable laws, following surrender of any such
Certificate, there shall be paid to the record holder of the certificates
representing whole shares of Parent Common Stock issued in
<PAGE>
exchange therefor, without interest, (i) at the time of such surrender, the
amount of cash payable in lieu of a fractional share of Parent Common Stock
to which such holder is entitled and the amount of dividends or other
distributions with a record date after the Effective Time theretofore paid
with respect to whole shares of Parent Common Stock, and (ii) after the
Effective Time but prior to surrender and a payment date subsequent to
surrender payable with respect to such whole shares of Parent Common Stock.
(d) NO FRACTIONAL SHARES. No fractional shares of Parent
Common Stock shall be issued in the Merger, but in lieu thereof each holder
of Company Common Stock otherwise entitled to a fraction of a share of Parent
Common Stock shall, upon surrender of his or her Certificate or Certificates,
be entitled to receive an amount of cash (without interest) determined by
multiplying the closing price for Parent Common Stock as reported on the New
York Stock Exchange (the "NYSE") Composite Transactions on the business day
two days prior to the Effective Date by the fractional share interest to
which such holder would otherwise be entitled.
(e) TERMINATION OF EXCHANGE FUND. Any portion of the Exchange
Fund which remains undistributed to the holders of Company Common Stock for
one year after the Effective Time shall be delivered to the Parent upon
demand, and any holders of Company Common Stock who have not theretofore
complied with this Article I shall thereafter look, subject to Section
1.8(d), only to Parent for payment of their claim for Parent Common Stock,
any cash in lieu of fractional shares of parent Common Stock and any dividend
or distributions with respect to Parent Common Stock.
(f) ABANDONED PROPERTY LAWS. Neither the Surviving Corporation
nor the Exchange Agent shall be liable to any holder of a Certificate for any
shares of Parent Common Stock (or dividends or distributions with respect
thereto or cash) from the Exchange Fund delivered to a public official
pursuant to any applicable abandoned property, escheat or similar law.
(g) TRANSFER TAXES. Except as provided in paragraph (b) above,
Parent shall pay or cause to be paid any transfer or gains tax (including,
without limitation, any real property gains or transfer tax) imposed in
connection with or as a result of the Merger, including any such transfer or
gains tax that is imposed on a shareholder of the Company.
1.9 STOCK TRANSFER BOOKS. At the Effective Time, the stock
transfer books of the Company shall be closed, and there shall be no further
registration of transfers of shares of Company Common Stock thereafter on the
records of the Company. At and after the Effective Time, any Certificates
presented to the Exchange Agent or the Surviving Corporation for any reason
shall be cancelled and exchanged as provided in this Article I.
1.10 COMPANY STOCK OPTIONS AND PLANS.
(a) VESTING; EXERCISABILITY. Effective at the Effective Time,
all outstanding stock options (the "COMPANY OPTIONS") to purchase shares of
Company Common Stock granted under the Company's Amended and Restated 1993
Combination Stock Option Plan, as
<PAGE>
amended, any Company individual stock plans and the Company's Directors'
Stock Option Plan, as amended (the "OPTION PLANS") shall be or, by the terms
of their respective stock option agreements will become, fully vested and
immediately exercisable in their entirety, pursuant to the terms of the
Option Plans.
(b) ELECTION OF OPTION HOLDER. At the Effective Time, each
holder of a Company Option shall have the right to elect to (a) exercise such
Company Options for shares of Company Common Stock (in which case such shares
of Company Common Stock will be converted into shares of Parent Common Stock
pursuant to Section 1.7 above); or (b) have each such Company Option assumed
in accordance with paragraphs (c) and (d) of this Section 1.10.
(c) ELECTION TO RECEIVE PARENT OPTIONS. At the Effective Time,
the Company's obligations with respect to each outstanding Company Option not
exercised as provided for in Section 1.10(b) hereof shall be assumed by
Parent (the "ASSUMED OPTIONS"). Except as specifically set forth in Section
1.10(d) below, the Assumed Options shall continue to have, and be subject to,
the same terms and conditions as set forth in the Option Plans and the stock
option agreement pursuant to which such Company Options were issued, as in
effect immediately prior to the Effective Time. It is the intention of the
parties hereto that, to the extent that any such Company Option constituted
an "incentive stock option" (within the meaning of Section 422 of the
Internal Revenue Code of 1986, as amended (the "CODE") immediately prior to
the Effective Time, such option shall continue to qualify as an incentive
stock option to the maximum extent permitted by Section 422 of the Code, and
that the assumption of the Company Options provided by this Section 1.10(d)
satisfy the conditions of Section 424(a) of the Code, and, therefore, the
provisions of this Section 1.10 shall be interpreted and applied in a manner
consistent with such intent.
(d) PARENT OPTIONS. Each Assumed Option shall be exercisable
for shares of Parent Common Stock in a number of shares of Parent Common
Stock equal to the number of shares of Company Common Stock for which such
Company Option was exercisable immediately prior to the Effective Time
multiplied by the Common Stock Exchange Ratio. The exercise price per share
of each Assumed Option shall be equal to the exercise price per share of such
option immediately prior to the Effective Time divided by the Common Stock
Exchange Ratio.
(e) RESERVATION OF SHARES. Parent shall reserve for issuance
the number of shares of Parent Common Stock that will become issuable upon
the exercise of the Assumed Options and, promptly after the Effective Time,
issue to each holder of an Assumed Option a document evidencing the
assumption by Parent of the Company's obligations with respect thereto.
Parent will use its best efforts to file and cause to become effective,
within 30 days after the Effective Time (or as soon thereafter as is
possible), a Registration Statement on Form S-8 under the Securities Act of
1933, as amended, registering the sale of the shares to be issued under the
Assumed Options. Parent will use its best efforts to keep such registration
statement effective until all of the Assumed Options have been exercised in
full or have expired unexercised.
<PAGE>
1.11 OTHER OUTSTANDING RIGHTS TO ACQUIRE OR RECEIVE COMPANY
COMMON STOCK.
(a) RIGHTS OUTSTANDING. At the Effective Time, the
Company shall have outstanding warrants, convertible promissory notes
and earnout rights ("COMPANY ACQUISITION RIGHTS"), pursuant to which the
Company shall be obligated to issue, in the aggregate, not more than
1,635,229 shares of Company Common Stock. A schedule of the Company
Acquisition Rights is set forth in Section 2.2 of the Company Disclosure
Schedule (as defined in Section 2.1 of this Agreement).
(b) RIGHT TO RECEIVE PARENT COMMON STOCK. At the
Effective Time, the Company Acquisition Rights shall be converted into
rights to acquire shares of Parent Common Stock ("PARENT ACQUISITION
RIGHTS") in a number equal to the number of shares of Company Common
Stock for which such Company Acquisition Right was exercisable
immediately prior to the Effective Time multiplied by the Common Stock
Exchange Ratio. The exercise price per share of each Company
Acquisition Right shall be equal to the exercise price per share of such
right immediately prior to the Effective Time divided by the Common
Stock Exchange Ratio.
(c) RESERVATION OF SHARES. Parent shall reserve for
issuance the number of shares of Parent Common Stock that will become
issuable upon the exercise of the Company Acquisition Rights and,
promptly after the Effective Time, issue to each holder of a Company
Acquisition Right a document evidencing the assumption by Parent of the
Company's obligations with respect thereto. Parent will use its best
efforts to ensure that shares of Parent Common Stock issued upon
exercise of Parent Acquisition Rights shall be registered under the
Securities Act and all applicable state securities laws, or be freely
tradeable under an available exemption from registration therefrom.
ARTICLE II
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
The Company hereby represents and warrants to Parent as follows:
2.1 ORGANIZATION AND QUALIFICATION. Each of the Company
and its subsidiaries (the "SUBSIDIARIES"), which are listed in Section
2.1 of the Company's disclosure schedule delivered to Parent in
connection with this Agreement (the "COMPANY DISCLOSURE SCHEDULE"), (a)
is duly organized, validly existing and in good standing under the laws
of the jurisdiction of its incorporation, (b) has all requisite
corporate power to carry on its business as it is now being conducted,
and (c) is in good standing and duly qualified to do business in each
jurisdiction in which the transaction of its business makes such
qualification necessary, except where the failure to be in good standing
or so qualified would not have a Material Adverse Effect (as defined in
Section 7.3(c) below) on the Company. True and complete copies of the
Amended and Restated Certificate of Incorporation and the Amended and
Restated Bylaws, as amended to date, of the Company have been delivered
to Parent.
<PAGE>
2.2 CAPITALIZATION OF THE COMPANY. The authorized capital
stock of the Company consists of 20,000,000 shares of Company Common
Stock, $.01 par value and 5,000,000 shares of preferred stock, $0.01 par
value ("Company Preferred Stock"). As of September 30, 1995, 8,002,425
shares of Company Common Stock were issued and outstanding, including
33,750 shares of Company Common Stock held by a subsidiary of the
Company and including 492,874 to be issued on the date immediately prior
to the Effective Time or January 2, 1996, whichever occurs sooner, and
no shares of Company Preferred Stock were outstanding. All outstanding
shares of Company Common Stock have been validly issued, and are fully
paid and nonassessable. Except as disclosed in the Company SEC
Documents (as defined in Section 2.6) or in Section 2.2 of the Company
Disclosure Schedule, there are no outstanding subscriptions, options,
warrants, calls, rights, commitments or any other agreement to which the
Company is a party or by which the Company is bound which, directly or
indirectly, obligate the Company to issue, deliver or sell or cause to
be issued, delivered or sold any additional shares of Company Common
Stock or any other capital stock of the Company or any other securities
convertible into, or exercisable or exchangeable for, or evidencing the
right to subscribe for any such shares.
2.3 AUTHORIZATION AND VALIDITY OF AGREEMENT. The
Company has all requisite corporate power and authority to enter into
this Agreement and to consummate the transactions contemplated hereby in
accordance with the terms hereof (subject to the approval and adoption
of this Agreement by the holders of a majority of the outstanding shares
of Company Common Stock). The Company's Board of Directors (the
"COMPANY BOARD") has duly authorized the execution, delivery and
performance of this Agreement by the Company, and no other corporate
proceedings on the part of the Company are necessary to authorize this
Agreement or the transactions contemplated hereby (other than the
approval and adoption of this Agreement and the Merger by the holders of
a majority of the outstanding shares of Company Common Stock). This
Agreement has been duly executed and delivered by the Company and,
assuming this Agreement constitutes the legal, valid and binding
obligation of Parent and Merger Sub, constitutes the legal, valid and
binding obligation of the Company, enforceable against the Company in
accordance with its terms, except as may be limited by any bankruptcy,
insolvency, reorganization, moratorium, fraudulent conveyance or other
similar laws affecting the enforcement of creditors' rights generally or
by general principles of equity (regardless of whether such
enforceability is considered in a proceeding in equity or at law).
2.4 CONSENTS AND APPROVALS.
(a) Neither the execution and delivery of this Agreement by
the Company nor the consummation by the Company of the transactions
contemplated hereby will require any consent, approval, authorization or
permit of, or filing with or notification to, any governmental or
regulatory authority by reason of the Company's status or operations,
except (i) in connection with the applicable requirements of the Hart-
Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR
ACT"), (ii) pursuant to the applicable requirements of the Securities
Act of 1933, as amended (the "SECURITIES ACT"), and the rules and
regulations promulgated thereunder, and the Securities Exchange Act of
1934, as amended (the "EXCHANGE ACT"), and the rules and regulations
promulgated thereunder, and state securities or "blue sky"
<PAGE>
laws and state takeover laws, (iii) the filing and recordation of the
Certificate of Merger pursuant to the DGCL and appropriate documents with
the relevant authorities of other states in which the Company is authorized
to do business, (iv) as set forth in Section 2.4 of the Company
Disclosure Schedule, or (v) where the failure to obtain such consent,
approval, authorization or permit, or to make such filing or
notification, would not in the aggregate have a Material Adverse Effect
on the Company or prevent the Merger.
(b) The Company Board has approved this Agreement and the
Merger for purposes of Section 203 of the DGCL so that Section 203 of
the DGCL is not applicable to the transactions provided for in this
Agreement. The affirmative vote of the holders of a majority of the
outstanding shares of Company Common Stock is the only vote of the
holders of capital stock of the Company necessary to approve the Merger.
2.5 NO VIOLATION. Except as set forth in Section 2.5 of
the Company Disclosure Schedule, assuming the Merger has been duly
approved by the holders of a majority of the outstanding shares of
Company Common Stock, neither the execution and delivery of this
Agreement by the Company nor the consummation by the Company of the
transactions contemplated hereby will (a) conflict with or violate the
Amended and Restated Certificate of Incorporation or Amended and
Restated Bylaws of the Company, (b) result in a violation or breach of,
constitute a default under, give rise to any right of termination,
cancellation or acceleration of, result in the imposition of any lien,
charge or other encumbrance on any material assets or property of the
Company pursuant to, any note, bond, mortgage, indenture, contract,
agreement, lease, license or other instrument or obligation to which the
Company is a party or by which the Company or any of its assets or
properties may be bound, except for such violations, breaches and
defaults (or rights of termination, cancellation or acceleration or lien
or other charge or encumbrance) as to which requisite waivers or
consents have been obtained or which in the aggregate would not have a
Material Adverse Effect on the Company or prevent the Merger, or (c)
assuming the consents, approvals, authorizations or permits and filings
or notifications referred to in Section 2.4 and this Section 2.5 are
duly and timely obtained or made and the approval of the Merger by the
holders of a majority of the outstanding shares of Company Common Stock
has been obtained, violate any order, writ, injunction, decree, statute,
rule or regulation applicable to the Company or any of its assets and
properties, except for such violations which would not in the aggregate
have a Material Adverse Effect on the Company or prevent the Merger.
2.6 SEC REPORTS; FINANCIAL STATEMENTS.
(a) Since April 14, 1994, the Company has filed with the
Securities and Exchange Commission (the "SEC") all forms, reports,
schedules, statements and other documents required to be filed by it
with the SEC pursuant to the Exchange Act, the Securities Act and the
SEC's rules and regulations thereunder (all such forms, reports and
other documents, including any such reports filed prior to the Effective
Time, collectively the "COMPANY SEC DOCUMENTS"). The Company SEC
Documents, including, without limitation, any financial statements or
schedules included therein, at the time filed, or in the case of
registration statements on their respective effective dates, (i)
complied in all material respects with the applicable requirements of
the Exchange Act and the Securities Act, as the case may
<PAGE>
be, and the applicable rules and regulations of the SEC thereunder and
(ii) did not at the time they were filed (or, in the case of registration
statements, at the time of effectiveness), contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements made therein, in light of the
circumstances under which they were made, not misleading.
(b) Each of the consolidated financial statements of the
Company (including any related notes thereto) included in the Company
SEC Documents comply as to form in all material respects with applicable
accounting requirements and with the published rules and regulations of
the SEC with respect thereto, have been prepared in accordance with
generally accepted accounting principles applied on a consistent basis
during the period involved (except as may be indicated in such financial
statements or in the notes thereto or, in the case of unaudited
financial statements, as permitted by the
requirements of Form 10-Q) and fairly present (subject, in the case of
the unaudited statements, to normal year-end adjustments and the absence
of footnotes) the consolidated financial position of the Company as of
the dates thereof and the consolidated results of the Company's
operations and cash flows for the periods presented therein.
2.7 FORM S-4 AND PROXY STATEMENT. None of the information
supplied or to be supplied by the Company for inclusion or incorporation
by reference in (i) the registration statement on Form S-4 to be filed
with the SEC by Parent in connection with the issuance of shares of
Parent Common Stock in the Merger (the "Form S-4") will, at the time the
Form S-4 is filed with the SEC and at the time it becomes effective
under the Securities Act, contain any untrue statement of material fact
or omit to state any material fact required to be stated therein or
necessary to make the statements therein not misleading, and (ii) the
proxy statement together with amendments thereof and supplements thereto
("PROXY STATEMENT") to be distributed to the stockholders of the Company
relating to the meeting of the Company's stockholders to consider and
vote on this Agreement and the Merger ("COMPANY'S STOCKHOLDERS'
MEETING") will contain, on the date the Proxy Statement or such
amendment or supplement is first mailed to stockholders, and at all
times subsequent thereto up to and including the Company's Stockholders'
Meeting, any statement which, at such time and in light of the
circumstances under which it will be made, will be false or misleading
with respect to any material fact, or will omit to state any material
fact required to be stated therein or necessary in order to make the
statements therein not false or misleading or necessary to correct any
statement in any earlier communication with respect to the Company's
Stockholders' Meeting which has become false or misleading. The Proxy
Statement, insofar as it relates to the Company, will comply in all
material respects with the provisions of the Exchange Act and the rules
and regulations promulgated thereunder.
2.8 COMPLIANCE WITH LAW. Except as set forth in Section
2.8 of the Company Disclosure Schedule, neither the Company nor any of
its subsidiaries is in violation of any applicable law, rule,
regulation, decree or order of any governmental or regulatory authority
applicable to the Company or any of its subsidiaries, except for
violations which in the aggregate do not have a Material Adverse Effect
on the Company. The Company holds all permits, licenses, exemptions,
order and approvals of all governmental and regulatory authorities
necessary for the lawful conduct of its businesses, except for failures
to hold
<PAGE>
permits, licenses, exemptions, orders and approvals which do not in the
aggregate have a Material Adverse Effect on the Company.
2.9 ABSENCE OF CERTAIN CHANGES. Except as disclosed in
the Company SEC Documents filed with the SEC prior to the date hereof,
since December 31, 1994, the Company has conducted its business only in
the ordinary course of such business and there has not been (i) any
Material Adverse Effect on the Company; (ii) any declaration, setting
aside or payment of any dividend or other distribution with respect to
its capital stock; or (iii) any material change in its accounting
principles, practices or methods.
2.10 LITIGATION. Except as disclosed in the Company SEC
Documents or as set forth in Section 2.10 of the Company Disclosure
Schedule, there are no claims, actions, proceedings or governmental
investigations pending or, to the knowledge of the Company, threatened
against the Company or any of its subsidiaries, by or before any court
or other governmental or regulatory body, which, if adversely
determined, would have a Material Adverse Effect on the Company. To the
knowledge of the Company, no action or proceeding has been instituted or
threatened before any court or other governmental or regulatory body by
any Person (as defined in Section 7.3) seeking to restrain or prohibit
the execution, delivery or performance of this Agreement or the
consummation of the transactions contemplated hereby.
2.11 EMPLOYEE BENEFIT MATTERS. All employee benefit plans
and other benefit arrangements covering employees of the Company and the
Company's subsidiaries are listed in the Company SEC Documents or in
Section 2.11 of the Company Disclosure Schedule, except such benefit
plans and other benefit arrangements which are not material (the
"Company Benefit Plans"). True and complete copies of the Company
Benefit Plans have been made available to Parent. To the extent
applicable, the Company Benefit Plans comply, in all material respects,
with the requirements of the Employee Retirement Income Security Act of
1974, as amended ("ERISA"), and the Code, and any Company Benefit Plan
intended to be qualified under Section 401(a) of the Code has received a
determination letter from the Internal Revenue Service (the "IRS")
stating that it is so qualified. No Company Benefit Plan is covered by
Title IV of ERISA or Section 412 of the Code. Neither any Company
Benefit Plan nor the Company has incurred any liability or penalty under
Section 4975 of the Code or Section 502(i) of ERISA. Each Company
Benefit Plan has been maintained and administered in all material
respects in compliance with its terms and with ERISA and the Code to the
extent applicable thereto. To the knowledge of the executive officers
of the Company, there are no pending or anticipated material claims
against or otherwise involving any of the Company Benefit Plans and no
suit, action or other litigation (excluding claims for benefits incurred
in the ordinary course of Company Benefit Plan activities) has been
brought against or with respect to any such Company Benefit Plan, except
for any of the foregoing which would not have a Material Adverse Effect
on the Company. All material contributions required to be made as of
the date hereof to the Company Benefit Plans have been made or provided
for. Neither the Company nor any entity under "common control" with the
Company within the meaning of ERISA Section 4001 has contributed to, or
been required to contribute to, any "multi-employer plan" (as defined in
Section 3(37) and 4001(a)(3) of ERISA). The Company does not maintain
or contribute to any plan or arrangement which provides or has any
liability to provide life insurance, medical or other employee welfare
benefits to any employee or former
<PAGE>
employee upon his retirement or termination of employment, except as required
by Section 4980B of the Code, and the Company has never represented, promised
or contracted (whether in oral or written form) to any employee or former
employee that such benefits would be provided. Except as disclosed in the
Company SEC Documents or the Company Disclosure Schedule or as provided in
Section 1.10 hereof, the execution of, and performance of the transactions
contemplated in, this Agreement will not (either alone or upon the occurrence
of any additional or subsequent events) constitute an event under any benefit
plan, policy, arrangement or agreement or any trust or loan that will or may
result in any payment (whether of severance pay or otherwise), acceleration,
forgiveness of indebtedness, vesting, distribution, increase in benefits or
obligations to fund benefits with respect to any employee.
2.12 TAXES. The Company and each of its subsidiaries (i)
has timely filed all material federal, state and foreign tax returns
required to be filed by any of them for tax years ended prior to the
date of this Agreement or requests for extensions have been timely filed
and any such request shall have been granted and not expired and all
such returns are complete in all material respects, (ii) has paid or
accrued all taxes shown to be due and payable on such returns, (iii) has
properly accrued all such taxes for such periods subsequent to the
periods covered by such returns, and (iv) has "open" years for federal
income tax returns only as set forth in the Company SEC Documents or in
Section 2.12 of the Company Disclosure Schedule.
2.13 INSURANCE. True and complete copies of all material
insurance policies maintained by the Company have been made available to
Parent. Such policies provide coverage for the operations of the
Company and its subsidiaries in amounts and covering such risks as the
Company believes is necessary to conduct its business. Neither the
Company nor any of its subsidiaries has received notice that any such
policy is invalid or unenforceable.
2.14 EMPLOYMENT AGREEMENTS. Except as disclosed in the
Company SEC Documents or as set forth in Section 2.14 of the Company
Disclosure Schedule, there are no material employment, consulting,
noncompetition, severance or indemnification agreements between the
Company and any current or former officer or director of the Company.
2.15 BROKERS AND FINDERS. No broker, finder or investment
bank has acted directly or indirectly for the Company, nor has the
Company incurred any obligation to pay any brokerage, finder's or other
fee or commission in connection with the transactions contemplated
hereby, other than Smith Barney Inc. ("SMITH BARNEY"), the fees and
expenses of which shall be borne by the Company.
2.16 OPINION OF FINANCIAL ADVISOR. Smith Barney has
delivered its opinion, dated the date of this Agreement, to the Board of
Directors of the Company to the effect that, as of the date of this
Agreement, the Merger Consideration to be received by the holders of
Company Common Stock is fair, from a financial point of view, to such
holders.
2.17 TAX MATTERS; POOLING. To the knowledge of the
Company, neither the Company nor any of its affiliates has taken or
agreed to take any action that would prevent the Merger from (i)
constituting a reorganization qualifying under the provisions of Section 368(a)
<PAGE>
of the Code or (ii) being treated for financial accounting
purposes as a "pooling of interests" in accordance with generally
accepted accounting principles ("GAAP") and the rules, regulations and
interpretations of the SEC (a "POOLING TRANSACTION").
2.18 AFFILIATES. Section 2.18 of the Company Disclosure
Schedule identifies all persons who, to the knowledge of the Company,
may be deemed to be affiliates of the Company under Rule 145 of the
Securities Act, including, without limitation, all directors and
executive officers of the Company.
2.19 CERTAIN BUSINESS PRACTICES. None of the Company, or
to the Company's knowledge any of its subsidiaries or any directors,
officers, agents or employees of the Company or any of its subsidiaries
(in their capacities as such) has (a) used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses relating
to political activity, (b) made any unlawful payment to foreign or
domestic government officials or employees or to foreign or domestic
political parties or campaigns or violated any provision of the Foreign
Corrupt Practices Act of 1977, as amended, (c) consummated any
transaction, made any payment, entered into any agreement or arrangement
or taken any other action in violation of Section 1128B(b) of the Social
Security Act, as amended, or (d) made any other unlawful payment, in all
cases except where the impact from such contributions, gifts,
entertainment, payments, violations, agreements, arrangements, actions
or payments would not in the aggregate have a Material Adverse Effect on
the Company.
2.20 PERMITS; COMPLIANCE.
(a) Except as disclosed in Section 2.02(a) of the Company
Disclosure Schedule, each of the Company and its subsidiaries is in
possession of (i) all franchises, grants, authorizations, licenses,
permits, easements, variances, exemptions, consents, certificates,
identification and registration numbers, approvals and orders necessary
to own, lease and operate its properties and to carry on its business as
it is now being conducted and (ii) agreements from all federal, state
and local governmental agencies and accrediting and certifying
organizations having jurisdiction over such facility or facilities that
are required to operate the facility or facilities in the manner in
which it or they are currently operated and receive reimbursement for
care provided to patients covered under the federal Medicare program or
any applicable state Medicaid program (collectively, the "COMPANY
PERMITS"), except where the failure to possess such Company Permits
could not reasonably be expected to have a Material Adverse Effect on
the Company. Without limiting the generality of the foregoing, certain
of the Company's facilities are certified for participation or
enrollment in the Medicare program, have a current and valid provider
contract with the Medicare program and are in substantial compliance
with the conditions of participation of such programs. Neither the
Company nor any of its subsidiaries has received notice from the
regulatory authorities that enforce the statutory or regulatory
provisions in respect to either the Medicare or Medicaid programs, of
any pending or threatened investigations or surveys, and no such
investigations or surveys are pending or, to the knowledge of the
Company, threatened or imminent that could reasonably be expected to
have a Material Adverse Effect on the Company. Section 2.20 of the
Company Disclosure Schedule sets forth, as of the date of this
Agreement, all actions, proceedings, investigations or surveys pending
or, to the knowledge of the Company,
<PAGE>
threatened against the Company or any of its subsidiaries that could
reasonably be expected to result in (i) the loss or revocation of a Company
Permit necessary to operate one or more facilities or for a facility to receive
reimbursement under the Medicare or Medicaid programs, (ii) the suspension
or cancellation of any other Company Permit, except any such Company Permit
where such suspension or cancellation could not reasonably be expected to
have a Material Adverse Effect on the Company. Except as set forth in
Section 2.20 of the Company Disclosure Schedule, neither the Company nor
any of its subsidiaries is in conflict with, or in default or violation of
(a) any law applicable to the Company or any of its subsidiaries or by or to
which any of their respective properties is bound or subject or (b) any
of the Company Permits, except for any such conflicts, defaults or
violations that could not reasonably be expected to have a Material
Adverse Effect on the Company. Except as set forth in Section 2.20 of
the Company Disclosure Schedule, since December 31, 1993, neither the
Company nor any of its subsidiaries has received from any Governmental
Entity (as defined in Section 4.9) any written notification with respect
to possible conflicts, defaults of violations of laws, except for
written notices relating to possible conflicts, defaults or violations
of laws, except for written notices relating to possible conflicts,
defaults or violations that could not reasonably be expected to have a
Material Adverse Effect on the Company.
(b) The Company and its subsidiaries, as appropriate, are
approved participating providers in and under all third-party payment
programs from which they receive revenues. No action or investigation
is pending, or to the best knowledge, threatened to suspend, limit,
terminate, condition or revoke the status of the Company or any of its
subsidiaries as a provider in any such program, and neither the Company
nor any of its subsidiaries has been provided notice by any third-party
payor of its intention to suspend, limit, terminate, revoke, condition
or fail to renew in whole or in part or decrease the amounts payable
under any arrangement with the Company or such subsidiary as a provider,
which action, investigation or proceeding would have a Material Adverse
Effect on the Company.
(c) The Company and its subsidiaries have filed on a
timely basis all claims, cost reports or annual filings required to be
filed to secure payments for services rendered by them under any third-
party payment program from which they receive or expect to receive
revenues, except where the failure to file such claim, report or other
filing would not have a Material Adverse Effect on the Company. Except
as indicated in its financial statements included in the Company SEC
Documents (as defined in Section 2.6 above), the Company or its
subsidiaries, as applicable, have paid, or caused to be paid, all
refunds, discounts, adjustments, or amounts owing that have become due
to such third-party payors pursuant to such claims, reports or filings,
and neither the Company nor any of its subsidiaries has any knowledge or
notice of any material changes required to be made to any cost reports,
claims or filings made by them for any period or of any deficiency in
any such claim, report, or filing, except for changes and deficiencies
that in the aggregate would not have a Material Adverse Effect on the
Company.
<PAGE>
ARTICLE III
REPRESENTATIONS AND WARRANTIES
OF PARENT AND MERGER SUB
Parent and Merger Sub hereby represent and warrant, jointly
and severally, to the Company as follows:
3.1 ORGANIZATION AND QUALIFICATION. Each of Parent and
its subsidiaries (the "Subsidiaries"), which is listed in Section 3.1 of
Parent's disclosure schedule delivered to the Company in connection with
this Agreement (the "PARENT DISCLOSURE SCHEDULE") (a) is duly organized,
validly existing and in good standing under the laws of the jurisdiction
of its incorporation, (b) has all requisite corporate power to carry on
its business as it is now being conducted and (c) is in good standing
and duly qualified to do business in each jurisdiction in which the
transaction of its business makes such qualification necessary, except
where the failure to be in good standing or so qualified would not have
a Material Adverse Effect on Parent. True and complete copies of their
respective Articles or Certificates of Incorporation, as the case may
be, and their respective Bylaws, as amended to date, have been delivered
to the Company.
3.2 CAPITALIZATION OF THE PARENT AND MERGER SUB.
(a) CAPITALIZATION OF PARENT. The authorized capital
stock of Parent consists of (i) 150,000,000 shares of Parent Common
Stock, of which, as of October 31, 1995: (A) 51,368,168 were issued and
outstanding, all of which are duly authorized, validly issued fully paid
and nonassessable and were not issued in violation of any preemptive or
similar rights created by statute, Parent's Certificate of Incorporation
or Bylaws or any agreement to which Parent is a party or is bound; (B)
476,099 were held by Chemical Mellon Shareholder Services as unexchanged
in respect of Parent's previous merger transaction with Continental
Medical Systems, Inc.; (C) 554,623 were held in the treasury of Parent;
and (D) 2,998,714 were reserved for future issuance; and (ii) 500,000
shares of preferred stock, par value $.001 per share ("PARENT PREFERRED
STOCK"), of which, as of October 31, 1995, 150,000 shares had been
designated Series A Junior Participating Preferred Stock. No shares of
Parent Preferred Stock are issued and outstanding. Except (1) as
disclosed in the Parent SEC Reports (as defined in Section 3.15 below)
or otherwise as set forth in this Section 3.2 or Section 3.2 of the
Parent Disclosure Schedule and (2) pursuant to the terms of that certain
Rights Agreement dated September 15, 1994 by and between Parent and
Chemical Trust Company of California (the "PARENT RIGHTS AGREEMENT"),
there are no options, warrants or other rights (including registration
rights), agreements, arrangements or commitments of any character to
which Parent or any of its subsidiaries is a party relating to the
issued or unissued capital stock of, or other equity interests in,
Parent or any of its subsidiaries. Except pursuant to the Parent Rights
Agreement or as set forth in Section 3.2 of the Parent Disclosure
Schedule, there are no obligations, contingent or otherwise, of Parent
or any of its subsidiaries to repurchase, redeem or otherwise acquire
any shares of Parent Common Stock or the capital stock of, or other
equity interests in, any subsidiary of Parent. Each of the issued
capital stock of, or other equity interests in, each of Parent's
subsidiaries is duly authorized, validly issued and, in the case of
<PAGE>
capital stock, fully paid and nonassessable, and has not been issued in
violation of (nor are any of the authorized shares of capital stock of,
or other equity interests in, such entities subject to) any preemptive
or similar rights created by statute, the Certificate of Incorporation
or Bylaws (or the equivalent organizational documents) of any of
Parent's subsidiaries, or any agreement to which Parent or any of its
subsidiaries is a party or bound.
(b) CAPITALIZATION OF MERGER SUB. The authorized capital
stock of Merger Sub consists of 1000 shares of common stock, par value
$.001 per share ("MERGER COMMON STOCK"). An aggregate of 100 shares of
Merger Sub Common Stock are issued and outstanding and held by Parent,
all of which are duly authorized, validly issued, fully paid and
nonassessable and not subject to preemptive rights created by statute,
Merger Sub's Certificate of Incorporation or Bylaws or any agreement to
which Merger Sub is a party or is bound.
3.3 AUTHORIZATION AND VALIDITY OF AGREEMENT. Each of
Parent and Merger Sub has all requisite corporate power and authority to
enter into this Agreement and to consummate the transactions
contemplated hereby in accordance with the terms hereof. The Boards of
Directors of Parent and Merger Sub, respectively, and Parent, as the
sole stockholder of Merger Sub, have duly authorized the execution,
delivery and performance of this Agreement by each of Parent and Merger
Sub, and no other corporate proceedings on the part of either Parent or
Merger Sub are necessary to authorize this Agreement or the transactions
contemplated hereby. This Agreement has been duly executed and
delivered by each of Parent and Merger Sub and, assuming this Agreement
constitutes the legal, valid and binding obligation of the Company,
constitutes the legal, valid and binding obligation of each of Parent
and Merger Sub, enforceable against each of Parent and Merger Sub in
accordance with its terms, except as may be limited by any bankruptcy,
insolvency, reorganization, moratorium or other similar laws affecting
the enforcement of creditors' rights generally or by general principles
of equity (regardless of whether such enforceability is considered in a
proceeding in equity or at law).
3.4 CONSENTS AND APPROVALS. Neither the execution and
delivery of this Agreement by Parent and Merger Sub nor the consummation
by Parent and Merger Sub of the transactions contemplated hereby will
require any consent, approval, authorization or permit of, or filing
with or notification to, any governmental or regulatory authority by
reason of Parent's or Merger Sub's status or (as applicable) operations,
except (a) in connection with the applicable requirements of the HSR
Act, (b) pursuant to the applicable requirements of the Securities Act,
the Exchange Act, the rules and regulations promulgated under such Acts,
and state securities or "blue sky" laws and state takeover laws, (c) the
filing and recordation of the Certificate of Merger pursuant to the
DGCL, (d) as set forth in Section 3.3 of the Parent Disclosure Schedule,
or (e) where the failure to obtain such consent, approval, authorization
or permit, or to make such filing or notification, would not in the
aggregate have a Material Adverse Effect on either of Parent or Merger
Sub or prevent the Merger.
3.5 NO VIOLATION. Except as set forth in Section 3.5 of
the Parent Disclosure Schedule, neither the execution and delivery of
this Agreement by Parent and Merger Sub nor the consummation by Parent
and Merger Sub of the transactions contemplated hereby will (a) conflict
with or violate the Articles or Certificate of Incorporation or Bylaws of
<PAGE>
Parent or Merger Sub, (b) result in a violation or breach of,
constitute (with or without notice or lapse of time or both) a default
under, give rise to any right of termination, cancellation or
acceleration of, result in the imposition of any lien, charge or other
encumbrance on any material assets or property of either of Parent or
Merger Sub pursuant to, any note, bond, mortgage, indenture, contract,
agreement, lease, license or other instrument or obligation to which
either of Parent or Merger Sub is a party or by which either of Parent
or Merger Sub or any of their respective assets or properties may be
bound, except for such violations, breaches and defaults or rights of
termination, cancellation or acceleration or lien or other consents have
been obtained or which in the aggregate would not have a Material
Adverse Effect on either of Parent or Merger Sub or prevent the Merger,
or (c) assuming the consents, approvals, authorizations or permits and
filings or notifications referred to in Section 3.3 and this Section 3.5
are duly and timely obtained or made, violate any order, writ,
injunction, decree, statute, rule or regulation applicable to either of
Parent or Merger Sub or any of their respective assets or properties,
except for such violations which would not in the aggregate have a
Material Adverse Effect on either of Parent or Merger Sub or prevent the
Merger.
3.6 COMPLIANCE WITH LAW. Except as set forth in Section
3.6 of the Parent Disclosure Schedule, neither the Parent nor any of its
subsidiaries is in violation of any applicable law, rule, regulation,
decree or order of any governmental or regulatory authority applicable
to the Parent or any of its subsidiaries, except for violations which in
the aggregate would not have a Material Adverse Effect on Parent.
Parent holds all permits, licenses, exemptions, order and approvals of
all governmental and regulatory authorities necessary for the lawful
conduct of its businesses, except for failures to hold permits,
licenses, exemptions, orders and approvals which would not in the
aggregate have a Material Adverse Effect on Parent.
3.7 ABSENCE OF CERTAIN CHANGES. Except as disclosed in
the Parent SEC Documents filed with the SEC prior to the date hereof,
since December 31, 1994, Parent has conducted its business only in the
ordinary course of such business and there has not been (i) any Material
Adverse Effect on Parent; (ii) any declaration, setting aside or payment
of any dividend or other distribution with respect to its capital stock;
or (iii) any material change in its accounting principles, practices or
methods.
3.8 EMPLOYEE BENEFIT MATTERS. All employee benefit plans
and other benefit arrangements covering employees of Parent and Parent's
subsidiaries are listed in the Parent SEC Documents or in Section 3.8 of
the Parent Disclosure Schedule, except such benefit plans and other
benefit arrangements which are not material (the "Parent Benefit
Plans"). True and complete copies of the Parent Benefit Plans have been
made available to Company. To the extent applicable, the Parent Benefit
Plans comply, in all material respects, with the requirements of ERISA
and the Code, and any Parent Benefit Plan intended to be qualified under
Section 401(a) of the Code has received a determination letter from the
IRS stating that it is so qualified. No Parent Benefit Plan is covered
by Title IV of ERISA or Section 412 of the Code. Neither any Parent
Benefit Plan nor the Parent has incurred any liability or penalty under
Section 4975 of the Code or Section 502(i) of ERISA. Each Parent
Benefit Plan has been maintained and administered in all material
respects in compliance with its terms and with ERISA and the Code to the
extent applicable thereto. To the knowledge of
<PAGE>
the executive officers of Parent, there are no pending or anticipated
material claims against or otherwise involving any of the Parent Benefit
Plans and no suit, action or other litigation (excluding claims for benefits
incurred in the ordinary course of Parent Benefit Plan activities) has been
brought against or with respect to any such Parent Benefit Plan, except for
any of the foregoing which would not have a Material Adverse Effect on the
Parent. All material contributions required to be made as of the date hereof
to the Parent Benefit Plans have been made or provided for. Neither Parent
nor any entity under "common control" with the Parent within the meaning of
ERISA Section 4001 has contributed to, or been required to contribute to, any
"multi-employer plan" (as defined in Section 3(37) and 4001(a)(3) of ERISA).
The Parent does not maintain or contribute to any plan or arrangement which
provides or has any liability to provide life insurance, medical or other
employee welfare benefits to any employee or former employee upon his
retirement or termination of employment, except as required by Section 4980B
of the Code, and Parent has never represented, promised or contracted
(whether in oral or written form) to any employee or former employee that
such benefits would be provided. Except as disclosed in the Parent SEC
Documents or the Parent Disclosure Schedule, the execution of, and
performance of the transactions contemplated in, this Agreement will not
(either alone or upon the occurrence of any additional or subsequent events)
constitute an event under any benefit plan, policy, arrangement or agreement
or any trust or loan that will or may result in any payment (whether of
severance pay or otherwise), acceleration, forgiveness of indebtedness,
vesting, distribution, increase in benefits or obligations to fund benefits
with respect to any employee.
3.9 TAXES. Parent and each of its subsidiaries (i) has timely
filed all material federal, state and foreign tax returns required to be
filed by any of them for tax years ended prior to the date of this Agreement
or requests for extensions have been timely filed and any such request shall
have been granted and not expired and all such returns are complete in all
material respects, (ii) has paid or accrued all taxes shown to be due and
payable on such returns, (iii) has properly accrued all such taxes for such
periods subsequent to the periods covered by such returns, and (iv) has
"open" years for federal income tax returns only as set forth in the Parent
SEC Documents or in Section 3.9 of the Parent Disclosure Schedule.
3.10 INSURANCE. True and complete copies of all material
insurance policies maintained by Parent have been made available to the
Company. Such policies provide coverage for the operations of the Parent and
its subsidiaries in amounts and covering such risks as the Parent believes is
necessary to conduct its business. Neither the Parent nor any of its
subsidiaries has received notice that any such policy is invalid or
unenforceable.
3.11 EMPLOYMENT AGREEMENTS. Except as disclosed in the Parent
SEC Documents or as set forth in Section 3.11 of the Parent Disclosure
Schedule, there are no material employment, consulting, noncompetition,
severance or indemnification agreements between the Parent and any current or
former officer or director of the Parent.
3.12 LITIGATION. Except as set forth in the Parent's SEC
Documents or as set forth in Section 3.12 of the Parent Disclosure Schedule,
there are no claims, actions, proceedings or governmental investigations
pending or, to the knowledge of Parent and Merger Sub, threatened against
either of Parent or any of its subsidiaries before any court or other
governmental or regulatory body, which, if adversely determined, would have a
Material
<PAGE>
Adverse Effect on either of Parent or Merger Sub. No action or proceeding
has been instituted or, to the knowledge of Parent or Merger Sub, threatened
before any court or other governmental or regulatory body by any Person
seeking to restrain or prohibit or to obtain damages with respect to the
execution, delivery or performance of this Agreement or the consummation of
the transactions contemplated hereby.
3.13 SUFFICIENT FUNDS. Parent has sufficient funds to (i) pay
in cash an amount necessary for the cancellation of the Company Stock Options
pursuant to Article I and (ii) pay when due or otherwise refinance all
indebtedness and other liabilities of the Company and its subsidiaries
outstanding at the Effective Time.
3.14 OPERATIONS OF MERGER SUB. Merger Sub has been formed
solely for the purpose of engaging in the transactions contemplated hereby,
and prior to the Effective Time will have engaged in no other business
activities, will have incurred no other liabilities or obligations other than
as contemplated herein, will have no subsidiaries, and will have conducted
its operations only as contemplated hereby.
3.15 SEC REPORTS AND FINANCIAL STATEMENTS; ABSENCE OF
UNDISCLOSED LIABILITIES.
(a) Since January 31, 1993, Parent has filed with the SEC (or
other regulatory authority) all forms, reports, schedules, statements and
other documents required to be filed by it pursuant to the Exchange Act and
the Securities Act and the SEC's rules and regulations thereunder (all such
forms, reports and other documents, including any such reports filed prior to
the Effective Time, collectively, the "PARENT SEC DOCUMENTS"). The Parent
SEC Documents, including, without limitation, any financial statements or
schedules included therein, at the time filed, or, in the case of
registration statements, on their respective effective dates, (a) complied in
all material respects with the applicable requirements of the Exchange Act
and the Securities Act, as the case may be, and the applicable rules and
regulations of the SEC thereunder and (b) did not at the time they were filed
(or, in the case of registration statements, at the time of effectiveness)
contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made,
not misleading.
(b) The consolidated financial statements of Parent (including
the related notes thereto) included in the Parent SEC Documents comply as to
form in all material respects with applicable accounting requirements and
with the published rules and regulations of the SEC with respect thereto,
have been prepared in accordance with generally accepted accounting
principles applied on a consistent basis during the period involved (except
as may be indicated in such financial statements or in the notes thereto or,
in the case of the unaudited financial statements, as permitted by the
requirements of Form 10-Q) and fairly present (subject, in the case of the
unaudited statements, to normal year-end adjustments and the absence of
footnotes) the consolidated financial position of Parent as of the dates
thereof and the consolidated results of Parent's operations and cash flows
for the periods presented therein.
<PAGE>
3.16 FORM S-4 AND PROXY STATEMENT. None of the information
supplied or to be supplied by Parent or Merger Sub for inclusion or
incorporation by reference in (i) the Form S-4 will, at the time the Form S-4
is filed with the SEC and at the time it becomes effective under the
Securities Act, contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make
the statements therein not misleading, and (ii) the Proxy Statement will, on
the date first mailed to stockholders and at all times subsequent thereto up
to and including the time of the Company's Stockholders' Meeting, contain any
statement which, at such time and in light of the circumstances under which
it will be made, will be false or misleading with respect to any material
fact, or will omit to state any material fact required to be stated therein
or necessary in order to make the statements therein not false or misleading
or necessary to correct any statement in any earlier communication with
respect to the Company's Stockholders' Meeting which has become false or
misleading. The Proxy Statement, insofar as it relates to Parent and Merger
Sub, will comply as to form in all material respects with the provisions of
the Exchange Act and the rules and regulations promulgated thereunder, and
the Form S-4 will comply as to form in all material respects with the
provisions of the Securities Act and the rules and regulations promulgated
thereunder.
3.17 BROKERS AND FINDERS. No broker, finder or investment bank
has acted directly or indirectly for either of Parent or Merger Sub, nor has
either of Parent or Merger Sub incurred any obligation to pay any brokerage,
finder's or other fee or commission in connection with the transactions
contemplated hereby.
3.18 TAX MATTERS; POOLING. To the knowledge of Parent, neither
Parent nor Merger Sub, nor any of their respective affiliates has taken or
agreed to take any action that would prevent the Merger from (i) constituting
a reorganization qualifying under the provisions of Section 368(a) of the
Code or (ii) being treated for financial accounting purposes as a Pooling
Transaction.
3.19 AFFILIATES. Section 3.19 of the Parent Disclosure Schedule
identifies all persons who, to the knowledge of Parent and Merger Sub, may be
deemed to be affiliates of the Company under Rule 145 of the Securities Act,
including, without limitation, all directors and executive officers of Parent
and Merger Sub.
3.20 CERTAIN BUSINESS PRACTICES. Neither Parent or Merger Sub,
or to Parent's or Merger Sub's knowledge, any of their respective
subsidiaries, or any directors, officers, agents or employees of Parent or
Merger Sub or any of their respective subsidiaries (in their capacities as
such) has (a) used any funds for unlawful contributions, gifts, entertainment
or other unlawful expenses relating to political activity, (b) made any
unlawful payment to foreign or domestic government officials or employees or
to foreign or domestic political parties or campaigns or violated any
provision of the Foreign Corrupt Practices Act of 1977, as amended, (c)
consummated any transaction, made any payment, entered into any agreement or
arrangement or taken any other action in violation of Section 1128B(b) of the
Social Security Act, as amended, or (d) made any other unlawful payment, in
all cases except where the impact from such contributions, gifts,
entertainment, payments, violations, agreements, arrangements,
<PAGE>
actions or payments would not in the aggregate have a Material Adverse Effect
on Parent or Merger Sub.
3.21 PERMITS; COMPLIANCE.
(a) Except as disclosed in Section 3.21 of the Parent
Disclosure Schedule, each of the Parent and its subsidiaries is in possession
of all (i) franchises, grants, authorizations, licenses, permits, easements,
variances, exemptions, consents, certificates, identification and
registration numbers, approvals and orders necessary to own, lease and
operate its properties and to carry on its business as it is now being
conducted and (ii) agreements from all federal, state and local governmental
agencies and accrediting and certifying organizations having jurisdiction
over such facility or facilities that are required to operate the facility or
facilities in the manner in which it or they are currently operated and
receive reimbursement for care provided to patients covered under the federal
Medicare program or any applicable state Medicaid program (collectively, the
"PARENT PERMITS"), except where the failure to possess such Parent Permits
could not reasonably be expected to have a Material Adverse Effect on the
Parent. Without limiting the generality of the foregoing, all of Parent's
hospitals are certified for participation or enrollment in the Medicare
program, have a current and valid provider contract with the Medicare program
and are in substantial compliance with the conditions of participation of
such programs. Neither Parent nor any of its subsidiaries has received
notice from the regulatory authorities that enforce the statutory or
regulatory provisions in respect of either the Medicare or Medicaid program
of any pending or threatened investigations or surveys, and no such
investigations or surveys are pending or, to the knowledge of the Parent,
threatened or imminent that could reasonably be expected to have Material
Adverse Effect on the Parent. Section 3.21 of Parent Disclosure Schedule
sets forth, as of the date of this Agreement, all actions, proceedings,
investigations or surveys pending or, to the knowledge of Parent, threatened
against Parent or any of its subsidiaries that could reasonably be expected
to result in (i) the loss or revocation of Parent, Permit necessary to
operate one or more facilities or for a facility to receive reimbursement
under the Medicare or Medicaid programs, (ii) the suspension or cancellation
of any other Parent Permit, except any such Parent Permit where such
suspension or cancellation could not reasonably be expected to have any
Material Adverse Effect on the Parent. Neither Parent nor any of its
subsidiaries is in conflict with, or in default or violation of (1) any law
applicable to Parent or any of its subsidiaries or by or to which any of
their respective properties is bound or subject or (2) any of Parent Permits,
except for any such conflicts, defaults or violations that could not
reasonably be expected to have a Material Adverse Effect on the Parent.
Since May 31, 1993, neither Parent nor any of its subsidiaries has received
from any Governmental Entity any written notification with respect to
possible conflicts, defaults or violations of laws, except for written
notices relating to possible conflicts, defaults or violations that could not
reasonably be expected to have a Material Adverse Effect on the Parent.
(b) Parent and its subsidiaries, as appropriate, are approved
participating providers in and under all third-party payment programs from
which they receive revenues. No action or investigation is pending, or to
the best of its knowledge, threatened to suspend, limit, terminate,
condition, or revoke the status of Parent or any of its subsidiaries as a
provider in any such program, and neither Parent nor any of its subsidiaries
have been provided notice by any third-party payor if its intention to
suspend,
<PAGE>
limit, terminate, revoke, condition or fail to renew in whole or in part
or decrease the amounts payable under the arrangement with Parent or
such subsidiary as a provider, which action, investigation or proceeding
would have a Parent Material Adverse Effect.
(c) Parent and its subsidiaries have filed on timely basis all
claims, cost reports or annual filings required to be filed to secure
payments for services rendered by them under any third-party payment
program from which they receive or expect to receive revenues, except
where the failure to file such claim, report or other filing would not
have a Material Adverse Effect on the Parent. Except as indicated in
its financial statements included in the Parent SEC Documents (as
defined in Section 3.15 above), Parent or its subsidiaries, as
applicable, have paid, or caused to be paid, all refunds, discounts,
adjustments, or amounts owing that have become due to such third-party
payors pursuant to such claims, reports or filings, and neither Parent
nor any of its subsidiaries has any knowledge or notice of any material
changes required to be made to any cost reports, claims or filings made
by them for any period or of any deficiency in any such claim, report,
or filing, except for changes and deficiencies that in the aggregate
would not have a Material Adverse Effect on the Parent.
ARTICLE IV
COVENANTS
4.1 CONDUCT OF BUSINESS PENDING THE MERGER. From the date
hereof until the Effective Time, except as otherwise required or
contemplated hereunder or as required by applicable law or as set forth
in Section 4.1 of the Company Disclosure Schedule in the case of the
Company and Section 4.1 of the Parent Disclosure Schedule in the case of
Parent, each of the Company and Parent shall:
(a) use all commercially reasonable efforts to conduct its
business and the business of its subsidiaries in all material
respects only in the ordinary course of business and consistent
with past practice;
(b) not amend its Amended and Restated Certificate of
Incorporation or Amended and Restated Bylaws or declare, set aside
or pay any dividend or other distribution or payment in cash,
stock or property in respect of its capital stock (other than
regular quarterly dividends);
(c) not reclassify, combine, split, subdivide or redeem,
purchase or otherwise acquire, directly or indirectly, any of its
capital stock;
(d) not issue, grant, sell or pledge or agree or authorize
the issuance, grant, sale or pledge of any shares of, or rights of
any kind to acquire any shares of, its capital stock other than
the grant of stock options in the ordinary course of business and
consistent with past practice under current employee benefit plan
arrangements and other than Company Common Stock or Parent Common
Stock,
<PAGE>
as the case may be, issuable upon the exercise of stock options or
issuable upon the exercise of convertibility features in its
securities outstanding on the date hereof;
(e) not acquire, sell, transfer, lease or encumber any
material assets except in the ordinary course of business and
consistent with past practice;
(f) use all commercially reasonable efforts to preserve
intact its business organizations and the business organizations
of its subsidiaries, and to keep available the services of its
present key officers and employees; PROVIDED, HOWEVER, that to
satisfy the foregoing obligation, neither the Company nor Parent
shall not be required to make any payments or enter into or amend
any contractual arrangements or understandings, except in the
ordinary course of business and consistent with past practice;
(g) not adopt a plan of complete or partial liquidation or
adopt resolutions providing for the complete or partial
liquidation, dissolution, consolidation, merger, restructuring or
recapitalization of the Company or Parent, as the case may be, or
any of its subsidiaries;
(h) not grant any severance or termination pay (otherwise
than pursuant to policies in effect on the date hereof) to, or
enter into any employment agreement with, any of its executive
officers or directors;
(i) not, except as set forth in Section 4.1 of the Company
Disclosure Schedule or the Parent Disclosure Schedule or in the
ordinary course of business consistent with past practice or
pursuant to obligations imposed by collective bargaining
agreements, increase the compensation payable or to become payable
to its executive officers or employees, enter into any contract or
other binding commitment in respect of any such increase with any
of its directors, officers or other employees or any director,
officer or other employee of its subsidiaries, and not establish,
adopt, enter into, make any new grants or awards under or amend,
any collective bargaining agreement or Plan, except as required by
applicable law, including any obligation to engage in good faith
collective bargaining, to maintain tax-qualified status or as may
be required by any Plan as of the date hereof;
(j) not settle or compromise any material claims or
litigation or, except in the ordinary course of business, modify,
amend or terminate any of its material contracts or waive, release
or assign any material rights or claims, or make any payment,
direct or indirect, of any material liability before the same
becomes due and payable in accordance with its terms;
(k) not take any action, other than reasonable and usual
actions in the ordinary course of business and consistent with
past practice with respect to accounting policies or procedures
(including tax accounting policies and procedures), except as may
be required by the SEC or the Financial Accounting Standards
Board;
<PAGE>
(l) not make any material tax election or permit any
material insurance policy naming it as a beneficiary or a loss
payable payee to be cancelled or terminated without notice to the
Company or Parent, as the case may be, except in the ordinary
course of business; and
(m) not authorize or enter into an agreement to do any of
the foregoing.
4.2 ACCESS; CONFIDENTIALITY.
(a) From the date of this Agreement until the Effective
Time, upon reasonable prior notice to the other party, the Company and
Parent each shall (and shall cause each of its subsidiaries to) give the
other party and its authorized representatives reasonable access during
normal business hours to its executive officers, properties, books and
records, and shall furnish the other party and its authorized
representatives with such financial and operating data and other
information concerning the business and properties of the Company or
Parent as the Company or Parent, as the case may be, may from time to
time reasonably request.
(b) Each of the Company and Parent will hold and will cause
its respective consultants, advisors and other representatives and
affiliates to keep all documents and information concerning the other
party and its subsidiaries furnished to the other party and its
representatives in connection with the transactions contemplated by this
Agreement confidential in accordance with the Confidentiality Agreement
dated August 23, 1995, between the Company and Parent, which
Confidentiality Agreement shall remain in full force and effect until
the termination of this Agreement.
4.3 FURTHER ACTIONS. Upon the terms and subject to the
conditions hereof, each of the parties hereto shall act in good faith
toward and use all commercially reasonable efforts to take, or cause to
be taken, all actions, and to do, or cause to be done, all things
necessary, proper or advisable, and consult and fully cooperate with and
provide reasonable assistance to each other party in order, to
consummate and make effective the transactions contemplated by this
Agreement as soon as practicable hereafter, including without limitation
(i) using all commercially reasonable efforts to obtain all consents,
approvals, authorizations or permits of governmental or regulatory
authorities (including early termination of any waiting period under the
HSR Act) or other Persons as are necessary for the consummation of the
transactions contemplated hereby, (ii) taking such actions and doing
such things as any other party hereto may reasonably request in order to
cause any of the conditions specified in Article V to such other party's
obligation to consummate such transactions to be fully satisfied, and
(iii) in the event and to the extent required, amending this Agreement
so that this Agreement and the Merger comply with the DGCL. Prior to
making any application to or filing with any governmental or regulatory
authority or other Person in connection with this Agreement, the
Company, on the one hand, and Parent and Merger Sub, on the other hand,
shall provide the other with drafts thereof and afford the other a
reasonable opportunity to comment on such drafts.
4.4 NOTICE OF CERTAIN MATTERS. The Company shall give
prompt notice to Parent, and Parent and Merger Sub shall give prompt
notice to the Company, of (a) the occurrence or nonoccurrence of any
event which would be likely to cause (i) any
<PAGE>
representation or warranty contained in this Agreement to be untrue or
inaccurate in any material respect or (ii) any covenant, condition or
agreement contained in this Agreement not to be complied with or satisfied
in all material respects and (b) any failure of the Company or of Parent or
Merger Sub, as the case may be, to comply with or satisfy any covenant,
condition or agreement to be complied with or satisfied by it hereunder in
any material respect.
4.5 FORM S-4, PROXY STATEMENT AND OTHER FILINGS.
(a) As soon as reasonably practicable, Parent shall prepare
the Form S-4 and the Company and Parent shall prepare the Proxy
Statement. Parent and the Company shall (i) file the Form S-4 and Proxy
Statement with the SEC promptly after it has been prepared in a form
reasonably satisfactory to the Company and Parent, and (ii) use
reasonable efforts to respond to the comments of the SEC thereon in a
manner reasonably satisfactory to the Company and Parent. Parent and
the Company shall promptly prepare any amendments to the Form S-4 and
Proxy Statement required in response to the SEC's comments or which
either the Company or Parent with the advice of counsel, deems necessary
or advisable. Parent shall take such actions as may be reasonably
required to cause the Form S-4 to be declared effective under the
Securities Act as promptly as possible. Parent also shall take such
actions as may be reasonably required to cause the shares of Parent
Common Stock issuable in the Merger to be registered (or to obtain an
exemption from registration) under applicable "blue sky" or state
securities laws and to be approved for listing on the NYSE upon official
notice of issuance.
(b) Each party shall notify the other party promptly after
receipt by such party of any comments of the SEC on, or of any request
by the SEC for amendments or supplements to, the Form S-4 or Proxy
Statement. Each party shall supply the other party with copies of all
correspondence between such party or any of it representatives and the
SEC with respect to any of the foregoing filings. Whenever Parent or
the Company shall learn of the occurrence of any event which should be
described in an amendment of, or a supplement to, the Company Proxy
Statement, such party shall promptly inform the other party and shall
cooperate to promptly cause such amendment or supplement to be prepared,
filed with and cleared by the SEC and, if required by applicable law,
disseminated to the persons in the manner required.
4.6 POOLING AND TAX-FREE REORGANIZATION TREATMENT.
Neither the Company nor Parent or Merger Sub shall intentionally take or
cause to be taken any action, whether on or prior to the Effective Time,
which would disqualify the Merger as a "pooling of interest" for
accounting purposes or as a "reorganization" within the meaning of
Section 368(a) of the Code.
4.7 AFFILIATE AGREEMENTS. The Company and Parent will
each use reasonable efforts to cause each of their respective directors,
executive officers and "affiliates" (within the meaning of Rule 145
under the Securities Act) to execute and deliver as soon as practicable
an agreement in form attached hereto as Exhibit 4.8 relating to the
disposition of shares of Parent Common Stock issuable to such person
pursuant to the Merger.
4.8 COMPANY'S STOCKHOLDERS' MEETING. As soon as
reasonably practicable after the date hereof, the Company will (a) duly
call and hold the Company's Stockholders'
<PAGE>
Meeting for the purpose of considering and voting upon the adoption of this
Agreement and the approval of the Merger, (b) include in the Proxy Statement
the determination and recommendation of its Board of Directors that
stockholders vote in favor of such matters, and (c) use commercially
reasonable efforts to solicit from its respective stockholders proxies
in favor of such approvals; PROVIDED, HOWEVER, that the Company's Board
of Directors may fail to make such a recommendation, or may withdraw,
modify or change any such recommendation, or recommend any other offer
or proposal, if the Company's Board of Directors determines in good
faith, after consultation with outside counsel, that making such
recommendation, or the failure to so withdraw, modify or change its
recommendation, or the failure to recommend any other offer or proposal,
could reasonably be deemed to cause the members of the Company's Board
of Directors to breach their fiduciary duties under applicable law. At
the Company's Stockholders' Meeting, Parent will (and will cause each
affiliate of Parent to) vote all shares of Company Common Stock which
are then owned by Parent or any affiliate thereof (other than natural
persons), and which are entitled to be voted upon the Merger, in favor
of approval and adoption of this Agreement and the Merger.
4.9 COOPERATION. Subject to the terms and conditions of
this Agreement and applicable law, each of the parties shall use its
reasonable efforts to take, or cause to be taken, all actions, and to
do, or cause to be done, all things necessary, proper or advisable to
consummate and make effective the transactions contemplated by this
Agreement as soon as practicable, including such actions or things as
any other party may reasonably request in order to cause any of the
conditions to such other party's obligation to consummate the
transactions contemplated by this Agreement to be fully satisfied.
Without limiting the foregoing, the parties shall (and shall cause their
respective subsidiaries, and use their reasonable efforts to cause their
respective affiliates, directors, officers, employees, agents,
attorneys, accountants and representatives, to) consult and fully
cooperate with and provide assistance to each other in (i) the
preparation and filing with the SEC of the Form S-4 and the Proxy
Statement and any necessary amendments or supplements thereto; (ii)
seeking to have the Form S-4 and Proxy Statement cleared by the SEC as
soon as reasonably practicable after filing; (iii) obtaining all
necessary consents, approvals, waivers, licenses, permits,
authorizations, registrations, qualifications, or other permission or
action by, and giving all necessary notices to and making all necessary
filings with and applications and submissions to, any court,
administrative agency or commission or other governmental authority or
instrumentality, domestic (federal, state or local) or foreign
(collectively, "GOVERNMENTAL ENTITY") or other person or entity as soon
as reasonably practicable after filing; (iv) seeking early termination
of any waiting period under the HSR Act; (v) providing all such
information about such party, its subsidiaries and its officers,
directors, partners and affiliates and making all applications and
filings as may be necessary or reasonably requested in connection with
any of the foregoing; (vi) in general, consummating and making effective
the transactions contemplated hereby; and (vii) in the event and to the
extent required, amending this Agreement so that this Agreement and the
Merger comply with the DGCL. The parties shall (and shall cause their
respective affiliates, directors, officers, employees, agents,
attorneys, accountants and representatives to) use their reasonable
efforts to cause the lifting of any permanent or preliminary injunction
or restraining order or other similar order issued or entered by any
court or other Governmental Entity preventing or restricting
consummation of the transactions contemplated hereby in the manner
provided for herein. Prior to making any application to or filing with
any Governmental Entity or other
<PAGE>
person or entity in connection with this Agreement (other than filing under
the HSR Act), each party shall provide the other party with drafts thereof
and afford the other party a reasonable opportunity to comment on such drafts.
4.10 PUBLIC ANNOUNCEMENTS. No party hereto shall or shall
permit any of its subsidiaries to (and each party shall use commercially
reasonable efforts to cause its affiliates, directors, officers,
employees, agents and representatives not to) issue any press release or
make any public statement concerning this Agreement or any of the
transactions contemplated hereby, without the prior written consent of
the other parties hereto; PROVIDED, HOWEVER, that a party may, without
the prior written consent of the other parties hereto, issue such a
press release or make such a public statement to the extent required by
applicable law or any listing agreement with a national securities
exchange by which such party is bound if it has used commercially
reasonable efforts to consult with the other parties and to obtain such
parties' consent but has been unable to do so in a timely manner.
4.11 ACQUISITION PROPOSALS. Except as contemplated
hereby, the Company shall not (and shall not permit any of its
subsidiaries to, and shall use its best efforts to cause its officers,
directors and employees and any investment banker, attorney, accountant,
or other agent retained by it or any of its subsidiaries not to)
initiate, solicit or encourage (including by way of furnishing
information or assistance), or take any other action to facilitate, any
inquiries or the making of any proposal relating to, or that may
reasonably be expected to lead to, acquire all or a significant part of
the business and properties or capital stock of the Company or its
subsidiaries, taken as a whole, whether by merger, purchase of assets,
tender offer or otherwise (a "COMPETING TRANSACTION"), or enter into
discussions or negotiate with any person or entity in furtherance of
such inquiries or to obtain a Competing Transaction, or agree to or
endorse any Competing Transaction, or authorize or knowingly permit any
of the officers, directors, employees or agents of the Company or its
subsidiaries or any investment banker, financial advisor, attorney,
accountant or other representative retained by the Company or any of its
subsidiaries to take any such action. The Company shall as promptly as
practicable notify Parent of all relevant terms of any such inquiries or
proposals received by the Company or its subsidiaries and, if such
inquiry or proposal is in writing, the Company shall as promptly as
practicable deliver or cause to be delivered to Parent a copy of such
inquiry or proposal. Notwithstanding the foregoing, nothing shall
prohibit the Company's Board of Directors from (a) furnishing
information to, or entering into discussions or negotiations with, any
persons or entity in connection with an unsolicited bona fide proposal
in connection with a Competing Transaction if, and only to the extent
that (i) such unsolicited bona fide proposal is on terms that the
Company's Board of Directors determines it cannot reject, based on
applicable fiduciary duties and the advice of counsel and (except with
respect to furnishing information) for which financing, to the extent
required, is then committed, or in the good faith judgment of the Board
of Directors could reasonably be expected to be obtained, and (ii) prior
to furnishing such information to, entering into discussions or
negotiations with, such person or entity the Company provides written
notice to Parent to the effect that it is furnishing information to, or
entering into discussions or negotiations with, such person or entity;
or (b) complying with Rule 14d-9 or Rule 14e-2 promulgated under the
Exchange Act with regard to a Competing Transaction.
<PAGE>
4.12 D&O INDEMNIFICATION.
(a) From the Effective Time through the later of (i) the sixth
anniversary of the date on which the Effective Time occurs and (ii) the
expiration of any statute of limitations applicable to any claim, action,
suit, proceeding or investigation referred to below, the Surviving
Corporation shall indemnify and hold harmless each present and former
director and officer of the Company and its subsidiaries, determined as of
the Effective Time (the "INDEMNIFIED PARTIES"), against any claims, losses,
liabilities, damages, judgments, fines, fees, costs or expenses, including
without limitation attorneys' fees and disbursements (collectively, "COSTS"),
incurred in connection with any claim, action, suit, proceeding or
investigation, whether civil, criminal, administrative or investigative,
arising out of or pertaining to matters existing or occurring at or prior to
the Effective Time (including, without limitation, the Merger, the
preparation, filing and mailing of the Proxy Statement and the other
transactions and actions contemplated by this Agreement), whether asserted or
claimed prior to, at or after the Effective Time, to the fullest extent that
the Company or such subsidiary would have been permitted, under applicable
law, indemnification agreements existing on the date hereof, the Amended and
Restated Articles or Certificate of Incorporation or Amended and Restated
Bylaws of the Company or such subsidiary in effect on the date hereof, to
indemnify such Person (and the Surviving Corporation shall also advance
expenses as incurred to the fullest extent permitted under applicable law
provided the person to whom expenses are advanced provides an undertaking to
repay such advances if it is ultimately determined that such person is not
entitled to indemnification).
(b) Any Indemnified Party wishing to claim indemnification
under this Section 4.12, upon learning of any such claim, action, suit,
proceeding or investigation, shall promptly notify the Surviving Corporation
thereof, but the failure to so notify shall not relieve the Surviving
Corporation of any liability or obligation it may have to such Indemnified
Party except, and only to the extent, that such failure materially prejudices
the Surviving Corporation. In the event of any such claim, action, suit,
proceeding or investigation (whether arising before, at or after the
Effective Time), the Surviving Corporation shall have the right to assume the
defense thereof and the Surviving Corporation shall not be liable to such
Indemnified Parties for any legal expenses of other counsel or any other
expenses subsequently incurred by such Indemnified Parties in connection with
the defense thereof, except that if the Surviving Corporation elects not to
assume such defense or counsel for the Indemnified Parties advises that there
are issues which raise conflicts of interest between the Surviving
Corporation and the Indemnified Parties, the Indemnified Parties may retain
counsel satisfactory to them, and the Surviving Corporation shall pay all
reasonable fees and expenses of such counsel for the Indemnified Parties
promptly as statements therefor are received. If such indemnity is not
available with respect to any Indemnified Party, then the Surviving
Corporation and the Indemnified Party shall contribute to the amount payable
in such proportion as is appropriate to reflect relative faults and benefits.
In the event that any claim or claims are
<PAGE>
asserted or made within the aforesaid six-year period, all rights to
indemnification in respect of any such claim or claims shall continue until
the final disposition of any and all such claims.
(c) Notwithstanding anything herein to the contrary, if any
claim, action, suit, proceeding or investigation (whether arising before, at
or after the Effective Time) is made against any present or former director
or officer of the Company, on or prior to the sixth anniversary of the
Effective Time, the provisions of this Section 4.12 shall continue in effect
until the final disposition of such claim, action, suit, proceeding or
investigation.
(d) This covenant is intended to be for the benefit of, and
shall be enforceable by, each of the Indemnified Parties and their respective
heirs and legal representatives. The indemnification provided for herein
shall not be deemed exclusive of any other rights to which an Indemnified
Party is entitled, whether pursuant to law, contract or otherwise.
(e) To the extent that the Surviving Corporation fails to
perform any of its obligations pursuant to this Section 4.12, Parent shall
assume the obligations and rights of the Surviving Corporation under this
Section 4.12.
4.13 THE COMPANY'S PLANS.
(a) Following the Effective Time, Parent shall cause the
Surviving Corporation to provide to persons who were employees of the Company
or any of its subsidiaries prior to the Effective Time (the "COMPANY
PERSONNEL") employee benefit plans, programs and arrangements (the "SURVIVING
CORPORATION PLANS") which in the aggregate are substantially comparable to
those employee benefit plans, programs and arrangements generally provided to
the employees of Parent as of the Effective Time.
(b) Following the Effective Time, Parent shall cause the
Surviving Corporation Plans to recognize any prior accrued service,
compensation credit, credit toward satisfying deductible expense
requirements, out-of-pocket expense limits and maximum lifetime benefit
limits of such Company Personnel and/or such Company Personnel's eligible
dependents, to the extent such prior service, credits and limits were
recognized under the comparable employee benefit plans, programs or
arrangements of the Company as of the Effective Time, for all purposes under
the Surviving Corporation Plans (including, but not limited to,
participation, eligibility, vesting and the calculation of benefits), and
Parent shall cause the Surviving Corporation Plans to waive any preexisting
condition, exclusion or limitation under any such Plan to the extent such
condition, exclusion or limitation would be covered by the comparable plan,
program or arrangement of the Company as of the Effective Time.
(c) Each of the employment agreements and the employment
security agreements for the benefit of Company Personnel identified in
Section 4.13(c)-I of the
<PAGE>
Company Disclosure Schedule shall be assumed by the Surviving Corporation at
the Effective Time on the same terms and subject to the same conditions as in
effect under such agreements immediately prior to the Effective Time (the
"ASSUMED AGREEMENTS").
(d) Parent hereby absolutely, irrevocably and unconditionally
guarantees the performance of all of the Surviving Corporation's obligations
under the Assumed Plans and the Assumed Agreements, as specified hereunder or
otherwise.
(e) Parent shall, and shall cause the Surviving Corporation to,
honor and fully defend all such agreements in accordance with their terms.
ARTICLE V
CLOSING CONDITIONS
5.1 CONDITIONS TO OBLIGATIONS OF EACH PARTY TO EFFECT THE
MERGER. The respective obligations of each party hereto to effect the Merger
shall be subject to the satisfaction at or prior to the Effective Time of the
following conditions, any or all of which may be waived, in whole or in part,
to the extent permitted by applicable law:
(a) STOCKHOLDER APPROVAL. This Agreement shall have been
adopted, and the Merger shall have been approved, by a vote of the holders of
a majority of the outstanding shares of Company Common Stock.
(b) NO INJUNCTION. No federal or state governmental or
regulatory body or court of competent jurisdiction shall have enacted,
issued, promulgated or enforced any statute, rule, regulation, executive
order, decree, judgment, preliminary or permanent injunction or other order
which is in effect and which prohibits, enjoins or otherwise restrains the
consummation of the Merger; PROVIDED, HOWEVER, that the parties shall use all
commercially reasonable efforts to cause any such decree, judgment,
injunction or order to be vacated or lifted.
(c) HSR ACT. Any waiting period under the HSR Act applicable
to the Merger shall have terminated or shall have otherwise expired.
(d) GOVERNMENTAL AND REGULATORY CONSENTS. All material filings
required to be made prior to the Effective Time with, and all material
consents, approvals, permits and authorizations required to be obtained prior
to the Effective Time from, governmental and regulatory authorities in
connection with the Merger and the consummation of the other transactions
contemplated hereby which are listed in Section 2.4 of the Company Disclosure
Schedule or Section 3.3 of the Parent Disclosure Schedule shall have been
made or obtained, as the case may be.
(e) REGISTRATION STATEMENT. The Form S-4 shall have become
effective in accordance with the provisions of the Securities Act, and no
stop order suspending such effectiveness shall have been issued and remain in
effect.
<PAGE>
(f) LISTING OF PARENT COMMON STOCK. The shares of Parent
Common Stock issuable in the Merger (including those issued in connection
with the Parent Acquisition Rights described in Section 1.11 above) shall
have been approved for listing on the NYSE upon official notice of issuance.
(g) POOLING. Each of the Company and Parent shall have
received a letter from its independent public accountants, dated the date of
the Proxy Statement and the Closing Date, in form and substance reasonably
satisfactory to the Company and Parent, as the case may be, stating that the
transactions contemplated by this Agreement will qualify as a
pooling-of-interests transaction under GAAP and applicable SEC regulations.
5.2 CONDITIONS PRECEDENT TO THE OBLIGATIONS OF THE COMPANY.
The obligation of the Company to effect the Merger is also subject to the
satisfaction at or prior to the Effective Time of each of the following
additional conditions, unless waived by the Company:
(a) ACCURACY OF REPRESENTATIONS AND WARRANTIES. All
representations and warranties made by Parent and Merger Sub herein shall be
true and correct in all material respects on and as of the Effective Time,
with the same force and effect as though such representations and warranties
had been made on and as of the Effective Time, except for changes permitted
or contemplated by this Agreement and except for representations and
warranties that are made as of a specific date or time, which shall be true
and correct in all material respects only as of such specific date or time.
(b) COMPLIANCE WITH COVENANTS. Each of Parent and Merger Sub
shall have performed in all material respects all obligations and agreements,
and complied in all material respects with all covenants, contained in this
Agreement to be performed or complied with by it prior to or on the Effective
Time.
(c) TAX OPINION. The Company shall have received an opinion
from Garvey, Schubert & Barer to the effect that the Merger will constitute a
reorganization within the meaning of Section 368(a) of the Code.
5.3 CONDITIONS PRECEDENT TO THE OBLIGATIONS OF PARENT AND
MERGER SUB. The obligation of Parent and Merger Sub to effect the Merger is
also subject to the satisfaction at or prior to the Effective Time of each of
the following additional conditions, unless waived by either of Parent or
Merger Sub:
(a) ACCURACY OF REPRESENTATIONS AND WARRANTIES. All
representations and warranties made by the Company herein shall be true and
correct in all material respects on and as of the Effective Time, with the
same force and effect as though such representations and warranties had been
made on and as of the Effective Time, except for changes permitted or
contemplated by this Agreement and except for representations and warranties
that are made as of a specific date or time, which shall be true and correct
in all material respects only as of such specific date or time.
<PAGE>
(b) COMPLIANCE WITH COVENANTS. The Company shall have
performed in all material respects all obligations and agreements, and
complied in all material respects with all covenants, contained in this
Agreement to be performed or complied with by it prior to or on the Effective
Time.
ARTICLE VI
TERMINATION
6.1 TERMINATION. This Agreement may be terminated at any time
prior to the Effective Time:
(a) by mutual written consent of the Company and Parent;
(b) by either the Company or Parent, if the Effective Time
shall not have occurred on or before April 1, 1996; PROVIDED,
HOWEVER, that the right to terminate this Agreement under this
clause (b) shall not be available to any party whose
misrepresentation in this Agreement or whose failure to perform
any of its covenants and agreements or to satisfy any obligation
under this Agreement has been the cause of or resulted in the
failure of the Merger to occur on or before such date;
(c) by either the Company or Parent, if any federal or
state court of competent jurisdiction or other federal or state
governmental or regulatory body shall have issued any judgment,
injunction, order or decree prohibiting, enjoining or otherwise
restraining the transactions contemplated by this Agreement and
such judgment, injunction, order or decree shall have become final
and nonappealable (PROVIDED, HOWEVER, that the party seeking to
terminate this Agreement pursuant to this clause (c) shall have
used all commercially reasonable efforts to remove such judgment,
injunction, order or decree) or if any statute, rule, regulation
or executive order promulgated or enacted by any federal or state
governmental authority after the date of this Agreement which
prohibits the consummation of the Merger shall be in effect;
(d) by the Company, if this Agreement is not adopted or
the Merger is not approved by the holders of a majority of the
outstanding shares of Company Common Stock;
(e) by Parent, if there shall have been a material breach
of any representation, warranty or material covenant or agreement
on the part of the Company, which breach is incurable or which is
not cured after thirty (30)-days' written notice by Parent to the
Company (a "TERMINATING COMPANY BREACH");
(f) by the Company, if there shall have been a material
breach of any representation, warranty or material covenant or
agreement on the part of either of Parent or Merger Sub, which
breach is incurable or which is not cured after thirty (30)-days'
written notice by the Company to Parent; or
<PAGE>
(g) by Parent if (i) the Company's Board of Directors
withdraws, its recommendation of this Agreement and the Merger, or
modifies or changes its recommendation of this Agreement or the
Merger in a manner materially adverse to the Parent, or shall have
resolved to do any of the foregoing, or the Company's Board of
Directors shall have recommended to the stockholders of the
Company any Competing Transaction or resolved to do so; (ii) a
tender offer or exchange offer for outstanding shares of capital
stock of the Company then representing 20% or more of the combined
power to vote generally for the election of directors is
commenced, and the Company's Board of Directors does not recommend
that stockholders not tender their shares of Company Common Stock
into such tender offer or exchange offer; or (iii) any person
shall have acquired beneficial ownership or the right to acquire
beneficial ownership of, or any "group" (as such term is defined
under Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder), shall have been formed which
beneficially owns, or has the right to acquire beneficial
ownership of, outstanding shares of capital stock of the Company
then representing 20% or more of the combined power to vote
generally for the election of directors; and
(h) by the Company or Parent, if the Company accepts a
bona fide written proposal made by a third party relating to a
Competing Transaction on terms that the Company's Board of
Directors determines it cannot reject in favor of the Merger,
based on applicable fiduciary duties and the advise of counsel and
for which financing, to the extent required, is then committed (a
"SUPERIOR PROPOSAL").
6.2 EFFECT OF TERMINATION. In the event of any termination of
this Agreement pursuant to Section 6.1, this Agreement forthwith shall become
void and of no further force or effect, and no party hereto (or any of its
affiliates, directors, officers, agents or representatives) shall have any
liability or obligation hereunder, except in any such case (a) as provided in
Sections 4.2(b) (Confidentiality), 4.9 (Public Announcements), 4.11
(Indemnification), 6.3 (Fees, Expenses and Other Payments) and Section 7.1,
which shall survive any such termination; and (b) to the extent such
termination results from the breach by such party, Parent or Merger Sub of
any of its representations, warranties, covenants or agreements contained in
this Agreement.
6.3 FEES, EXPENSES AND OTHER PAYMENTS.
(a) PAYMENT OF EXPENSES. Except as provided in Sections 6.3(b)
and (c) of this Agreement, all reasonable out-of-pocket expenses (including,
without limitation, all reasonable fees and expenses of counsel, accountants,
investment bankers, experts and consultants to a party hereto and its
affiliates) incurred by a party or on its behalf in connection with or
related to the authorization, preparation, negotiation, execution and
performance of this Agreement, the preparation, printing, filing and mailing
of the Registration Statement and the Company Proxy Statement, the
solicitation of stockholder approvals and all other matters relating to the
consummation of the transactions contemplated hereby ("EXPENSES") incurred by
the parties hereto shall be borne solely and entirely by the party which
incurred such Expenses; PROVIDED, HOWEVER, Parent, at its option may pay any
Expenses of the Company.
<PAGE>
Notwithstanding the foregoing, the allocable share of the Parent and Merger
Sub as a group and the Company for all Expenses relating to printing, filing
and mailing the Registration Statement and the Company Proxy Statement, and
all SEC and other regulatory filing fees incurred in connection with the
Registration Statement and the Company Proxy Statement shall be borne equally
by the Parent and Merger Sub as a group and the Company.
(b) The Company agrees that, if (i) this Agreement is
terminated pursuant to Section 6.1 (g) and, prior to the Company's
Stockholders' Meeting, the Company shall have furnished information to,
entered into discussions or negotiations with, any person or entity with
respect to a Competing Transaction and the Company's Board of Directors
shall not have reaffirmed its recommendations to the stockholders of the
Company with respect to the transactions contemplated by this Agreement
by the time of the Company's Stockholders' Meeting; (ii) the Company or
Parent terminates this Agreement pursuant to Section 6.1(h); or (iii)
the Company or Parent terminates this Agreement pursuant to Section
6.1(e) at a time that a Terminating Company Breach exists (except
solely for purposes of this Section 6.3(b) a breach of a representation
shall not be deemed to be a Terminating Company Breach if the
representation was true and correct as of the date hereof) then, (x) in
the case of (ii) of this Section 6.3(b), if, within six months following
termination (the "SIX-MONTH DATE"), a Competing Transaction is not
consummated, then the Company shall pay to Parent on the Six-Month Date,
the actual expenses of Parent up to $1 million, plus a fee equal to
$500,000, payable, at the election of the Company, in cash or Company
Common Stock (the market value of such stock shall be determined by the
closing price of the Company Common Stock on the Six-Month Date, or, if
such date is not a day on which the NASDAQ Stock Market is available for
trading, then on the last day for which a stock price is available), or
(y) in the case of (i), (ii) or (iii) of this Section 6.3(b), if a
Competing Transaction has been consummated before the Six-Month Date or
a definitive agreement subsequently resulting in a Competing Transaction
has been executed before the Six-Month Date, then the Company shall pay
to Parent, on the date of the closing of the Competing Transaction, the
actual expenses of Parent up to $1 million, plus a fee equal to $2.1
million, reduced by any payments previously made by the Company to
Parent pursuant to clause (x) above. In addition, in the case of (i),
(ii) or (iii) above, to the extent that the Profit (as defined in the
Stock Option Agreement between the parties hereto and executed on even
date herewith) realized upon exercise of the option granted thereunder
exceeds $1 million (the "EXCESS PROFIT"), then the amount of such Excess
Profit shall be set off against any other payments to be paid by the
Company pursuant to this Section 6.3(b), or, if such payments have
already been paid to Parent, Parent shall promptly return, to the extent
not applied to such set-off, such Excess Profit to the Company up to the
amount of the payments previously paid pursuant to this Section 6.3(b).
ARTICLE VII
MISCELLANEOUS
7.1 NO SURVIVAL. None of the representations warranties,
covenants or agreements contained in this Agreement or in any
certificate or other instrument delivered pursuant to this Agreement
shall survive the Effective Time, except for the covenants and
<PAGE>
agreements contained in Articles I and VII and Sections 4.2(b)
(Confidentiality), 4.10 (Public Announcements), 4.12 (D&O Indemnification and
Insurance), 4.13 (Company Plans) and 6.3 (Fees, Expenses and Other Payments).
7.2 NOTICES. All notices and other communications given
or made pursuant hereto shall be in writing and shall be deemed to have
been duly given or made as of the date delivered, mailed or transmitted,
and shall be effective upon receipt, if delivered personally, mailed by
registered or certified mail (postage prepaid, return receipt requested)
or sent by facsimile (with immediate confirmation) or nationally
recognized overnight courier service, as follows:
(a) if to Parent or Merger Sub, to:
Horizon/CMS Healthcare Corporation
6001 Indian School Road, N.E.
Albuquerque, New Mexico 97110
Attn: Scot Sauder
Fax: 505/881-5097
with a copy to:
Vinson & Elkins, L.L.P.
2300 First City Tower
1001 Fannin
Houston, Texas 7702-6760
Attn: William E. Joor III
Fax:
(b) if to the Company, to:
Pacific Rehabilitation & Sports Medicine, Inc.
Suite 190
8100 N.E. Parkway Drive
Vancouver, Washington 98662
Attn: John A. Elorriaga
Fax: 360/260-8130
with a copy to:
Garvey, Schubert & Barer
11th Floor
121 S.W. Morrison Street
Portland, Oregon 97204
Attn: Michael McArthur-Phillips
Fax: 503/226-0259
<PAGE>
or to such other Person or address or facsimile number as any party
shall specify by like written notice to the other parties hereto (any
such notice of a change of address to be effective only upon actual
receipt thereof).
7.3 CERTAIN DEFINITIONS. The following terms shall, when
used in this Agreement, have the following respective meanings:
(a) "AFFILIATE" shall have the meaning assigned to such
term in Section 12(b)-2 of the Exchange Act.
(b) "BUSINESS DAY" shall have the meaning set forth in Rule
14d-1(c)(6) under the Exchange Act.
(c) "MATERIAL ADVERSE EFFECT" means, with respect to any
Person, any change or effect which is materially adverse to the
financial condition or results of operations of such Person and
its subsidiaries, taken as a whole, excluding in all cases: (i)
events or conditions generally affecting the industry in which
such Person and its subsidiaries operate or arising from changes
in general business or economic conditions; (ii) all out-of-pocket
fees and expenses (including without limitation legal, accounting,
investigatory, and other fees and expenses) incurred in connection
with the transactions contemplated by this Agreement; (iii) in the
case of the Company, the payment by the Company and/or its
subsidiaries of all amounts due to any officers or employees of
the Company or any of its subsidiaries under employment contracts
or other employee benefit plans in effect as of the date hereof;
(iv) any effect resulting from any change in law or generally
accepted accounting principles, which affect generally entities
such as such Person; and (v) any effect resulting from compliance
by such Person with the terms of this Agreement.
(d) "PERSON" means any natural person, corporation,
limited liability company, partnership, unincorporated
organization or other entity.
(e) "SUBSIDIARY" of any Person means any other corporation
or entity of which such Person owns, directly or indirectly, stock
or other equity interests having a majority of the votes entitled
to be cast in the election of directors of such corporation or
entity under ordinary circumstances or of which such Person owns a
majority beneficial interest.
7.4 ENTIRE AGREEMENT. This Agreement (including the
schedules, exhibits and other documents referred to herein), together
with the Confidentiality Agreement referred to in Section 4.2(b),
constitutes the entire agreement between and among the parties hereto
and supersedes all prior agreements and understandings, oral and
written, between or among any of the parties with respect to the subject
matter hereof.
7.5 ASSIGNMENT; BINDING EFFECT. Neither this Agreement
nor any of the rights, benefits or obligations hereunder may be
assigned, in whole or in part, by any party (whether by operation of law
or otherwise) without the prior written consent of the other
<PAGE>
parties hereto. Subject to the preceding sentence, this Agreement shall be
binding upon, inure to the benefit of and be enforceable by the parties
and their respective successors and assigns. Nothing in this Agreement,
expressed or implied, is intended to confer on any person other than the
parties or their respective successors and assigns, any rights,
remedies, obligations or liabilities under or by reason of this
Agreement, other than rights conferred upon Indemnified Parties under
Section 4.11.
7.6 AMENDMENTS. This Agreement may be amended by the
parties at any time prior to the Effective Time; PROVIDED, HOWEVER, that
after approval of the Merger and this Agreement by the stockholders of
the Company, no amendment shall be made which by law requires further
approval by the stockholders of the Company, without such approval.
This Agreement may not be amended or modified except by an instrument in
writing signed on behalf of each of the parties hereto.
7.7 WAIVERS. At any time prior to the Effective Time,
Parent (for Parent and Merger Sub), on the one hand, or the Company, on
the other hand, may, to the extent legally allowed, (a) extend the time
specified herein for the performance of any of the obligations or other
acts of the other, (b) waive any inaccuracies in the representations and
warranties of the other contained herein or in any document delivered
pursuant hereto, or (c) waive compliance by the other with any of the
agreements or covenants of such other party or parties (as the case may
be) contained herein. Any such extension or waiver shall be valid only
if set forth in a written instrument signed on behalf of the party or
parties to be bound thereby. No such extension or waiver shall
constitute a waiver of, or estoppel with respect to, any subsequent or
other breach or failure to strictly comply with the provisions of this
Agreement. The failure of any party to insist on strict compliance with
this Agreement or to assert any of its rights or remedies hereunder or
with respect hereto shall not constitute a waiver of such rights or
remedies.
7.8 CAPTIONS. The Table of Contents and headings
contained in this Agreement are for reference purposes only and shall
not affect in any way the meaning or interpretation of this Agreement.
7.9 COUNTERPARTS. This Agreement may be executed in
counterparts, each of which shall be deemed to be an original, and all
of which together shall be deemed to be one and the same instrument.
<PAGE>
7.10 GOVERNING LAW. This Agreement shall be governed by
and construed in accordance with the internal laws of the State of
Delaware, without regard to any applicable principles of conflicts of
law.
IN WITNESS WHEREOF, the parties have executed this Agreement
and Plan of Merger as of the date first above written.
PACIFIC REHABILITATION & SPORTS
MEDICINE, INC.
By: /s/ JOHN A. ELORRIAGA
--------------------------------------
Name: John A. Elorriaga
Title: President and Chief Executive
Officer
HORIZON/CMS HEALTHCARE CORPORATION
By: /S/ CHARLES GONZALES
--------------------------------------
Name: Charles Gonzales
Title: Senior Vice President of
Subsidiary Operations
HORIZON PRSM CORPORATION
By: /s/ CHARLES GONZALES
--------------------------------------
Name: Charles Gonzales
Title: Senior Vice President
<PAGE>
EXHIBIT 2.2
STOCK OPTION AGREEMENT
STOCK OPTION AGREEMENT, dated as of November 9, 1995 by and among
Horizon/CMS Healthcare Corporation, a Delaware corporation ("Acquiror"), and
Pacific Rehabilitation & Sports Medicine, Inc., a Delaware corporation (the
"Company").
WHEREAS, concurrently with the execution and delivery of this
Agreement, Acquiror, the Company, and Horizon PRSM Corporation, a Delaware
corporation ("Merger Sub") are entering into an Agreement and Plan of
Merger, dated as of the date hereof (the "Merger Agreement"), which provides,
among other things, upon the terms and subject to the conditions thereof, for
the merger of the Company into Merger Sub (the "Merger"); and
WHEREAS, as a condition to Acquiror's willingness to enter into the
Merger Agreement, Acquiror has requested that the Company agree, and the
Company has so agreed, to grant to Acquiror an option with respect to certain
shares of the Company's common stock, on the terms and subject to the
conditions set forth herein.
NOW, THEREFORE, to induce Acquiror to enter into the Merger Agreement,
and in consideration of the mutual covenants and agreements set forth herein
and in the Merger Agreement, the parties hereto agree as follows:
1. GRANT OF OPTION. The Company hereby grants Acquiror an
irrevocable option (the "Company Option") to purchase from the Company upon
original issue up to a number of shares of common stock, par value $.01 per
share ("Company Common Stock"), of the Company equal to 15% of number of
shares of Common Stock outstanding on date of this Agreement, subject to
adjustment as provided in Section 11 (such shares being referred to herein as
the "Company Shares") in the manner set forth below at an exercise price of
$7.75 per Company Share (the "Exercise Price"), payable at Acquiror's option,
(a) in cash or (b), subject to the Company's having obtained the approvals of
any Governmental Entity (as defined in the Merger Agreement) required for the
Company to acquire the Acquiror Shares (as defined below) from Acquiror, which
approvals the Company shall use all reasonable efforts to obtain, in shares of
common stock, par value $.001 per share, of Acquiror ("Acquiror Shares"), in
either case in accordance with Section 4 hereof. Notwithstanding the
foregoing, in no event shall the number of shares for which the Company Option
is exercisable exceed 15% of the number of issued and outstanding Company
Shares. Capitalized terms used herein but not defined herein shall have the
meanings set forth in the Merger Agreement.
2. EXERCISE OF OPTION. The Company Option may be exercised by
Acquiror, in whole or in part, at any time or from time to time after the
Merger Agreement becomes terminable by Acquiror under circumstances that, if
the Merger Agreement were terminated as a result thereof and a Competing
Transaction (as defined in the Merger Agreement) were consummated before the
Six Month Date (as defined in the Merger Agreement), would entitle Acquiror to
actual expenses (as defined in the Merger Agreement) under Section 6.3(b) of
the Merger Agreement, any event
<PAGE>
by which the Merger Agreement becomes so terminable by Acquiror being
referred to herein as a "Trigger Event." For purposes of the Merger Agreement,
the term "Profits" shall mean the aggregate amount received (whether in cash,
loan proceeds, securities or otherwise) by Acquiror in the sale, transfer or
other disposition ("Sale") of Company Shares less the Exercise Price of such
Company Shares sold in the Sale. The Company shall notify Acquiror promptly
in writing of the occurrence of any Trigger Event, it being understood that
the giving of such notice by the Company shall not be a condition to the right
of Acquiror to exercise the Company Option. If Acquiror wishes to exercise the
Company Option, Acquiror shall deliver to the Company a written notice (an
"Exercise Notice") specifying the total number of Company Shares it wishes to
purchase. Each closing of a purchase of Company Shares (a "Closing") shall
occur at a place, on a date and at a time designated by Acquiror in an Exercise
Notice delivered at least two business days prior to the date of the Closing.
The Company Option shall terminate upon the earlier of: (i) the Effective Time;
(ii) the termination of the Merger Agreement pursuant to Section 6.1 thereof
(other than upon or during the continuance of a Trigger Event); or (iii) 180
days following any termination of the Merger Agreement upon or during the
continuance of a Trigger Event (or if, at the expiration of such 180 day
period the Company Option cannot be exercised by reason of any applicable
judgment, decree, order, law or regulation, ten business days after such
impediment to exercise shall have been removed or shall have become final and
not subject to appeal, but in no event under this clause (iii) later than
September 1, 1996). Notwithstanding the foregoing, the Company Option may not
be exercised if Acquiror is in material breach of any of its material
representations or warranties, or in material breach of any of its covenants
or agreements, contained in this Agreement or in the Merger Agreement. Upon
the giving by Acquiror to the Company of the Exercise Notice and the tender of
the applicable aggregate Exercise Price, Acquiror shall be deemed to be the
holder of record of the Company Shares issuable upon such exercise,
notwithstanding that the stock transfer books of the Company shall then be
closed or that certificates representing such Company Shares shall not then
be actually delivered to Acquiror.
3. CONDITIONS TO CLOSING. The obligation of the Company to issue
the Company Shares to Acquiror hereunder is subject to the conditions, which
(other than the conditions described in clauses (i), (iii) and (iv) below) may
be waived by the Company in its sole discretion, that (i) all waiting periods,
if any, under the HSR Act, applicable to the issuance of the Company Shares
hereunder shall have expired or have been terminated; (ii) the Company Shares,
and any Acquiror Shares which are issued in payment of the Exercise Price,
shall have been approved for listing on either the NYSE or the National
Association of Securities Dealers Automated Quotation System ("NASDAQ"), as
the case may be, upon official notice of issuance; (iii) all consents,
approvals, orders or authorizations of, or registrations, declarations or
filings with, any Governmental Entity, if any, required in connection with the
issuance of the Company Shares hereunder shall have been obtained or made, as
the case may be; and (iv) no preliminary or permanent injunction or other
order by any court of competent jurisdiction prohibiting or otherwise
restraining such issuance shall be in effect.
2
<PAGE>
4. CLOSING. At any Closing, (a) the Company will deliver to
Acquiror or its designee a single certificate in definitive form representing
the number of the Company Shares designated by Acquiror in its Exercise Notice,
such certificate to be registered in the name of Acquiror and to bear the
legend set forth in Section 11, and (b) Acquiror will deliver to the Company
the aggregate price for the Company Shares so designated and being purchased
by (i) wire transfer of immediately available funds or certified check or bank
check or (ii) subject to the condition in Section 1(b), a certificate or
certificates representing the number of Acquiror Shares being issued by
Acquiror in consideration thereof, as the case may be. For the purposes of
this Agreement, the number of Acquiror Shares to be delivered to the Company
shall be equal to the quotient obtained by dividing (i) the product of (x) the
number of Company Shares with respect to which the Company Option is being
exercised and (y) the Exercise Price by (ii) the Fair Market Value (as
hereinafter defined) of the Acquiror Shares on the date immediately preceding
the date the Exercise Notice is delivered to the Company. As used herein,
the "Fair Market Value" of any share shall be the average of the daily closing
sales price for such share on the New York Stock Exchange (the "NYSE") during
the ten NYSE trading days prior to the fifth NYSE trading day preceding the
date such Fair Market Value is to be determined. The Company shall pay all
expenses, and any and all United States federal, state and local taxes and
other charges that may be payable in connection with the preparation, issue
and delivery of stock certificates under this Section 4 in the name of
Acquiror or its designee.
5. REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company
represents and warrants to Acquiror that (a) the Company has taken all
necessary corporate action to authorize and reserve for issuance and to permit
it to issue, upon exercise of the Company Option, and at all times from the
date hereof through the expiration of the Company Option will have reserved,
1,500,000 authorized and unissued Company Shares, such amount being subject to
adjustment as provided in Section 10, all of which, upon their issuance and
delivery in accordance with the terms of this Agreement, will be validly
issued, fully paid and nonassessable, (b) upon delivery of the Company Shares
to Acquiror upon the exercise of the Company Option, Acquiror will acquire the
Company Shares free and clear of all claims, liens, charges, encumbrances and
security interests of any nature whatsoever, (c) none of the Company, any of
its affiliates or anyone acting on its or their behalf has issued, sold or
offered any security of the Company to any person under circumstances, or
taken any other action, that would cause the issuance and sale of the Option
Shares, as contemplated by this Agreement, to be subject to the registration
requirements of the Securities Act as in effect on the date hereof and,
assuming the representations of Acquiror contained in Section 6(c) are true
and correct, the issuance, sale and delivery of the Option Shares hereunder
upon exercise of the Company Option will be exempt from the registration and
prospectus delivery requirements of the Securities Act, as in effect on the
date hereof and (d) any Acquiror Shares acquired by the Company pursuant to
this Agreement will be acquired for the Company's own account and will not be
acquired by the Company with a view to the distribution thereof in violation
of any applicable provision of the Securities Act.
6. REPRESENTATIONS AND WARRANTIES OF ACQUIROR. Acquiror represents
and warrants to the Company that (a) prior to any delivery of Acquiror Shares
in consideration of the purchase of
3
<PAGE>
Company Shares pursuant hereto, Acquiror will have taken all necessary
corporate action to authorize for issuance and to permit it to issue such
Acquiror Shares, all of which, upon their issuance and delivery in accordance
with the terms of this Agreement, will be validly issued, fully paid and
nonassessable, (b) upon any delivery of such Acquiror Shares to the Company
in consideration of the purchase of Company Shares pursuant hereto, the
Company will acquire the Acquiror Shares free and clear of all claims, liens,
charges, encumbrances and security interests of any nature whatsoever, (c)
any Company Shares acquired upon exercise of the Company Option will be
acquired for Acquiror's own account, and will not be, and the Company Option
is not being, acquired by Acquiror with a view to the distribution thereof in
violation of any applicable provision of the Securities Act.
7. VOTING OF SHARES. Following the date hereof and prior to the
fifth anniversary of the date hereof (the "Expiration Date"), each party shall
vote any shares of capital stock of the other party acquired by such party
pursuant to this Agreement, including any Acquiror Shares issued pursuant to
Section 1(b) ("Restricted Shares") or otherwise beneficially owned (within the
meaning of Rule 13d-3 promulgated under the Securities Exchange Act of 1934,
as amended (the "Exchange Act") by such party on each matter submitted to a
vote of stockholders of such other party for and against such matter in the
same proportion as the vote of all other stockholders of such other party are
voted (whether by proxy or otherwise) for and against such matter.
8. RESTRICTIONS ON TRANSFER.
(a) RESTRICTIONS ON TRANSFER. Prior to the Expiration Date,
neither party shall, directly or indirectly, by operation of law or otherwise,
sell, assign, pledge, or otherwise dispose of or transfer any Restricted
Shares beneficially owned by such party, other than in accordance with
Section 8(b) or Section 9.
(b) PERMITTED SALES. Following the termination of the Merger
Agreement, a party shall be permitted to sell any Restricted Shares
beneficially owned by it if such sale is made pursuant to a tender or exchange
offer that has been approved or recommended, or otherwise determined to be
fair to and in the best interests of the stockholders of the other party, by a
majority of the members of the Board of Directors of such other party which
majority shall include a majority of directors who were directors prior to the
announcement of such tender or exchange offer.
9. REGISTRATION RIGHTS. Following the termination of the Merger
Agreement, each party hereto (a "Designated Holder") may by written notice
(the "Registration Notice") to the other party (the "Registrant") request the
Registrant to register under the Securities Act all or any part of the
Restricted Shares beneficially owned by such Designated Holder (the
"Registrable Securities") pursuant to a bona fide firm commitment underwritten
public offering in which the Designated Holder and the underwriters shall
effect as wide a distribution of such Registrable Securities as is reasonably
practicable and shall use all reasonable efforts to prevent any Person
(including any Group) and its affiliates from purchasing through such offering
Restricted Shares
4
<PAGE>
representing more than 1% of the outstanding shares of common stock of the
Registrant on a fully diluted basis (a "Permitted Offering"). The
Registration Notice shall include a certificate executed by the Designated
Holder and its proposed managing underwriter, which underwriter shall be an
investment banking firm of nationally recognized standing (the "Manager"),
stating that (i) they have a good faith intention to commence promptly a
Permitted Offering and (ii) the Manager in good faith believes that, based on
the then prevailing market conditions, it will be able to sell the
registrable Securities at a per share price equal to at least 80% of the then
Fair Market Value of such shares. The Registrant (and/or any Person
designated by the Registrant) shall thereupon have the option exercisable by
written notice delivered to the Designated Holder within ten business days
after the receipt of the Registration Notice, irrevocably to agree to
purchase all or any part of the Registrable Securities for cash at a price
(the "Option Price") equal to the product of (i) the number of Registrable
Securities and (ii) the then Fair Market Value of such shares. Any such
purchase of Registrable Securities by the Registrant (or its designee)
hereunder shall take place at a closing to be held at the principal executive
offices of the Registrant or at the offices of its counsel at any reasonable
date and time designated by the Registrant and/or such designee in such
notice within 20 business days after delivery of such notice. Any payment
for the shares to be purchased shall be made by delivery at the time of such
closing of the Option Price in immediately available funds.
If the Registrant does not elect to exercise its option pursuant
to this Section 10 with respect to all Registrable Securities, it shall use
all reasonable efforts to effect, as promptly as practicable, the registration
under the Securities Act of the unpurchased Registrable Securities; PROVIDED,
HOWEVER, that (i) neither party shall be entitled to more than an aggregate of
two effective registration statements hereunder and (ii) the Registrant will
not be required to file any such registration statement during any period of
time (not to exceed 40 days after such request in the case of clause (A) below
or 90 days in the case of clauses (B) and (C) below) when (A) the Registrant
is in possession of material non-public information which it reasonably
believes would be detrimental to be disclosed at such time, and in the opinion
of counsel to the Registrant, such information would have to be disclosed if a
registration statement were filed at that time; (B) the Registrant is required
under the Securities Act to include audited financial statements for any
period in which registration statement and such financial statements are not
yet available for inclusion in such registration statement; or (C) the
Registrant determines, in its reasonable judgment, that such registration
would interfere with any financing, acquisition or other material transaction
involving the Registrant or any of its affiliates. The Registrant shall use
reasonable efforts to cause any Registrable Securities registered pursuant to
this Section 9 to be qualified for sale under the securities or Blue Sky laws
of such jurisdictions as the Designated Holder may reasonably request and
shall continue such registration or qualification in effect in such
jurisdiction; PROVIDED, HOWEVER, that the Registrant shall not be required to
qualify to do business in, or consent to general service of process in, any
jurisdiction by reason of this provision.
The registration rights set forth in this Section 9 are subject
to the condition that the Designated Holder shall provide the Registrant with
such information with respect to such holder's Registrable Securities, the
plans for the distribution thereof, and such other information
5
<PAGE>
with respect to such holder as, in the reasonable judgment of counsel for the
Registrant, is necessary to enable the Registrant to include in such
registration statement all material facts required to be disclosed with
respect to a registration thereunder.
A registration effected under this Section 9 shall be effected
at the Registrant's expense, except for underwriting discounts and commissions
and the fees and the expenses of counsel to the Designated Holder, and the
Registrant shall provide to the underwriters such documentation (including
certificates, opinions of counsel and "comfort" letters from auditors) as are
customary in connection with underwritten public offerings as such
underwriters may reasonably require. In connection with any such
registration, the parties agree (i) to indemnify each other and the
underwriters in the customary manner, (ii) to enter into an underwriting
agreement in form and substance customary for transactions of such type with
the Manager and the other underwriters participating in such offering and
(iii) to take all further actions which shall be reasonably necessary to
effect such registration and sale (including, if the Manager deems it
necessary, participating in road-show presentations).
The Registrant shall be entitled to include (at its expense)
additional shares of its common stock in a registration effected pursuant to
this Section 9 only if and to the extent the Manager determines that such
inclusion will not adversely affect the prospects for success of such
offering.
10. ADJUSTMENT UPON CHANGES IN CAPITALIZATION. Without limiting any
restriction on the Company contained in this Agreement or in the Merger
Agreement, in the event of any change in Company Common Stock by reason of
stock dividends, splitups, mergers (other than the Merger),
recapitalizations, combinations, exchange of shares or the like, the type and
number of shares or securities subject to the Company Option, and the purchase
price per share provided in Section 1, shall be adjusted appropriately to
restore to Acquiror its rights hereunder, including the right to purchase from
the Company (or its successors) shares of Company Common Stock representing
15% of the outstanding Company Common Stock for the aggregate Exercise Price
calculated as of the date of this Agreement as provided in Section 1.
11. RESTRICTIVE LEGENDS. Each certificate representing shares of
Company Common Stock issued to Acquiror hereunder, and Acquiror Shares, if
any, delivered to the Company at a Closing, shall include a legend in
substantially the following form:
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY
BE REOFFERED OR SOLD ONLY IF SO REGISTERED OR IF AN EXEMPTION FROM
SUCH REGISTRATION IS AVAILABLE. SUCH SECURITIES ARE ALSO SUBJECT
TO ADDITIONAL RESTRICTIONS ON TRANSFER AS SET FORTH IN THE STOCK
OPTION AGREEMENT, DATED AS OF NOVEMBER 9, 1995, A COPY OF WHICH
MAY BE OBTAINED FROM THE ISSUER UPON REQUEST.
6
<PAGE>
It is understood and agreed that: (i) the reference to the resale
restrictions of the Securities Act in the above legend shall be removed by
delivery of substitute certificate(s) without such reference if Acquiror or
the Company, as the case may be, shall have delivered to the other party a
copy of a letter from the staff of the Securities and Exchange Commission, or
an opinion of counsel, in form and substance satisfactory to the other party,
to the effect that such legend is not required for purposes of the Securities
Act; (ii) the reference to the provisions to this Agreement in the above
legend shall be removed by delivery of substitute certificate(s) without such
reference if the shares have been sold or transferred in compliance with the
provisions of this Agreement and under circumstances that do not require the
retention of such reference; and (iii) the legend shall be removed in its
entirety if the conditions in the preceding clauses (i) and (ii) are both
satisfied. In addition, such certificates shall bear any other legend as may
be required by law. Certificates representing shares sold in a registered
public offering pursuant to Section 10 shall not be required to bear the
legend set forth in this Section 11.
12. BINDING EFFECT; NO ASSIGNMENT; NO THIRD PARTY BENEFICIARIES.
This Agreement shall be binding upon and inure to the benefit of the parties
hereto and their respective successors and permitted assigns. Except as
expressly provided for in this Agreement, neither this Agreement nor the rights
or the obligations of either party hereto are assignable, except by operation
of law, or with the written consent of the other party. Nothing contained in
this Agreement, express or implied, is intended to confer upon any person other
than the parties hereto and their respective permitted assigns any rights or
remedies of any nature whatsoever by reason of this Agreement. Any Restricted
Shares sold by a party in compliance with the provisions of Section 9 shall,
upon consummation of such sale, be free of the restrictions imposed with
respect to such shares by this Agreement, unless and until such party shall
repurchase or otherwise become the beneficial owner of such shares, and any
transferee of such shares shall not be entitled to the registration rights of
such party.
13. SPECIFIC PERFORMANCE. The parties hereby acknowledge and agree
that the failure of the Company to perform its agreement and covenants
hereunder will cause irreparable injury to the Acquiror for which damages,
even if available, will not be an adequate remedy. Accordingly, the Company
hereby consents to the issuance of injunctive relief by any court of competent
jurisdiction to compel performance of the Company's obligations and to the
granting by any such court of the remedy of specific performance of its
obligations hereunder.
14. ENTIRE AGREEMENT. This Agreement and the Merger Agreement
(including the exhibits and schedules thereto) constitute the entire agreement
of the parties, and supersedes all prior agreements and undertakings, both
written and oral, among the parties, with respect to the subject matter
hereof.
15. FURTHER ASSURANCES. Each party will execute and deliver all
such further documents and instruments and take all such further action as may
be necessary in order to consummate the transactions contemplated hereby.
7
<PAGE>
16. VALIDITY. The invalidity or unenforceability of any provision
of this Agreement shall not affect the validity or enforceability of the other
provisions of this Agreement, which shall remain in full force and effect. If
any court or other competent authority holds any provisions of this Agreement
to be null, void or unenforceable, the parties hereto shall negotiate in good
faith the execution and delivery of an amendment to this Agreement in order,
as nearly as possible, to effectuate, to the extent permitted by law, the
intent of the parties hereto with respect to such provision and the economic
effects thereof. Each party agrees that, should any court or other competent
authority hold any provision of this Agreement or part hereof to be null, void
or unenforceable, or order any party to take any action inconsistent herewith,
or not take any action required herein, the other party shall not be entitled
to specific performance of such provision or part hereof or to any other
remedy, including without limitation money damages, for breach hereof or of
any other provision of this Agreement or part hereof as the result of such
holding or order.
17. NOTICES. All notices and other communications hereunder shall
be in writing and shall be deemed given in the manner provided in the Merger
Agreement.
18. GOVERNING LAW. This Agreement shall be governed by, and
construed in accordance with, the laws of the State of Delaware, regardless of
the laws that might otherwise govern under applicable principles of conflicts
of law.
19. HEADINGS. The headings contained in this Agreement are for
reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement.
20. COUNTERPARTS. This Agreement may be executed in multiple
counterparts, and by the different parties hereto in separate counterparts,
each of which when executed shall be deemed to be an original but all of which
taken together shall constitute one and the same agreement.
21. EXPENSES. Except as otherwise expressly provided herein or in
the Merger Agreement, all costs and expenses incurred in connection with the
transactions contemplated by this Agreement shall be paid by the party
incurring such expenses.
22. AMENDMENTS; WAIVER. This Agreement may be amended by the
parties hereto and the terms and conditions hereof may be waived only by
an instrument in writing signed on behalf of each of the parties hereto or,
in the case of a waiver, by an instrument signed on behalf of the party
waiving compliance.
23. EXTENSION OF TIME PERIODS. The time periods for exercise of
certain rights under Sections 2 and 6 shall be extended (i) to the extent
necessary to obtain all regulatory approvals for the exercise of such rights,
and for the expiration of all statutory waiting periods and (ii) to the extent
necessary to avoid any liability under Section 16(b) of the Exchange Act by
reason of such exercise.
8
<PAGE>
24. REPLACEMENT OF COMPANY OPTION. Upon receipt by the Company of
evidence reasonably satisfactory to it of the loss, theft, destruction or
mutilation of this Agreement, and (in the case of loss, theft or destruction)
of reasonably satisfactory indemnification, and upon urrender and cancellation
of this Agreement, if mutilated, the Company will execute and deliver a new
Agreement of like tenor and date.
9
<PAGE>
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to
be executed by their respective duly authorized officers as of the date first
above written.
HORIZON/CMS HEALTHCARE CORPORATION
By /s/ Charles H. Gonzales
-----------------------------------
Name: Charles H. Gonzales
Title: Senior Vice President of
Subsidiary Operations
PACIFIC REHABILITATION & SPORTS
MEDICINE, INC.
By /s/ John A. Elorriaga
-----------------------------------
Name: John A. Elorriaga
Title: Chairman of the Board and
Chief Executive Officer
10
<PAGE>
EXHIBIT 2.3
VOTING AGREEMENT
VOTING AGREEMENT ("Agreement") dated as of March 31, 1995,
between Horizon/CMS Healthcare Corporation, a Delaware corporation
("Acquiror"), and the undersigned stockholders (collectively, the
"Stockholders") of Pacific Rehabilitation & Sports Medicine, Inc., a
Delaware corporation (the "Company").
WITNESSETH:
WHEREAS, the Stockholders beneficially own an aggregate of
856,565 shares (together with any additional shares as to which
beneficial ownership is acquired by any member of the Stockholder
Group described below, the "Company Shares") of Common Stock, par
value $.01 per share ("Company Common Stock"), of the Company.
WHEREAS, Acquiror is prepared to enter into an Agreement and
Plan of Merger with the Company (the "Merger Agreement") providing
for the merger of a wholly owned subsidiary of Acquiror into the
Company and the conversion in such merger of each share of Company
Common Stock into the number of shares of the Common Stock, par
value $.001 per share, of Acquiror set forth in the Merger Agreement
(the "Merger");
WHEREAS, the Stockholders fully support the Merger and, in
order to encourage Acquiror to enter into the Merger Agreement
with the Company, the Stockholders are willing to enter into
certain arrangements with respect to the Company Shares;
NOW THEREFORE, in consideration of the premises set forth
above, the mutual promises set forth below, and other good and
valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties hereto agree as follows:
1. STOCKHOLDERS' SUPPORT OF THE MERGER. From the date
hereof until November 15, 1996, or, if earlier, termination of the
Merger Agreement:
(a) No Stockholder or any corporation or other person
controlled by any Stockholder or any affiliate or associate
thereof, other than the Company and its subsidiaries
(collectively, the "Stockholder Group"), will, directly or
indirectly, sell, transfer, pledge or otherwise dispose of, or
grant a proxy with respect to, any Company Shares to any
person other than Acquiror or its designee, or grant an option
with respect to any of the foregoing, or enter into any other
agreement or arrangement with respect to any of the foregoing.
(b) No Stockholder or any other member of the
Stockholder holder Group will initiate, solicit or encourage
(including by way of furnishing information or assistance), or
take any other action to facilitate, any inquiries or the
making of any proposal relating to, or that may
reasonably be expected to lead to, any merger, consolidation,
share exchange, business combination or similar transaction
involving the Company or any of its subsidiaries or the
acquisition in any manner, directly or indirectly, of a
material equity interest in any voting securities of, or a
substantial portion of the assets of, the Company or any of
its Significant Subsidiaries, other than the transactions
contemplated by this Agreement (a "Competing Transaction"), or
enter into discussions or negotiate with any person or entity
in furtherance
<PAGE>
of such inquiries or to obtain a Competing Transaction, or
agree to, or endorse, any Competing Transaction, or authorize
or permit any of the officers, directors or employees of any
Stockholder or any member of the Stockholder Group or any
investment banker, financial advisor, attorney, accountant or
other representative retained by any Stockholder or any other
member of the Stockholder Group to take any such action. Each
Stockholder shall promptly notify Acquiror of all relevant
terms of any such inquiries or proposals received by such
Stockholder or any other member of the Stockholder Group or by
any such officer, director, employee, investment banker,
financial advisor, attorney, accountant or other
representative relating to any of such matters and if such
inquiry or proposal is in writing, such Stockholder shall
deliver or cause to be delivered to Acquiror a copy of such
inquiry or proposal.
(c) The Stockholders agree that the Stockholders
will vote, and will cause each member of the Stockholder Group to
vote, all Company Shares beneficially owned by such persons
(I) in favor of the Merger and (ii) subject to the provisions
of paragraph (d) below, against any combination proposal or
other matter that may interfere or be inconsistent with the
Merger (including without limitation a Competing Transaction).
(d) The Stockholders agree that, if
requested by Acquiror, it will not, and it will cause each
member of the Stockholder Group not to, attend or vote any
Company Shares beneficially owned by any such person at any
annual or special meeting of stockholders, or execute any
written consent of stockholders, during such period.
(e) The Stockholders shall take all
affirmative steps reasonably requested by Acquiror to indicate
their full support for the Merger, and hereby consent to
Acquiror's announcement in any press release, public filing,
advertisement or other document, that the Stockholders fully
support the Merger.
(f) Acquiror and the Stockholders agree that they shall
use all reasonable efforts to seek the successful completion
of the Merger in an expeditious manner.
(g) To the extent inconsistent with the provisions of
this Section 2, each member of the Stockholder Group hereby
revokes any and all proxies with respect to such member's
Company Shares or any other voting securities of the Company.
Nothing in this Agreement shall be deemed to prohibit any Stockholder from
acting in accordance with such Stockholder's fiduciary duties solely to the
extent that such Stockholder is acting in the capacity of officer or director
of the Company.
2. MISCELLANEOUS.
(a) The Stockholders, on the one hand,
and Acquiror, on the other, acknowledge and agree that
irreparable damage would occur if any of the provisions of
this Agreement were not performed in accordance with their
specific terms or were otherwise breached. It is accordingly
agreed that the parties shall be entitled to an injunction or
injunctions to prevent breaches of the provisions of this
Agreement and to enforce specifically the terms and
<PAGE>
provisions hereof in any court of the United States or any
state thereof having jurisdiction, in addition to any other
stockholder to which they may be entitled at law or equity.
(b) Descriptive headings are for convenience only and
shall not control or affect the meaning or construction of
any provision of this Agreement.
(c) All notices, consents, requests, instructions,
approvals and other communications provided for herein shall
be validly given, made or served, if in writing and delivered
personally, by telecopier or sent by registered mail, postage
prepaid:
If to Acquiror:
Horizon/CMS Healthcare Corporation
6001 Indian School Road, N.E.
Suite 530
Albuquerque, NM 87110
Attn: Neal M. Elliott
Telecopier No: (505) 881-5097
with a copy to:
Vinson & Elkins L.L.P.
2300 First City Tower
1001 Fannin
Houston, Texas 77002-6760
Attention: William E. Joor III
Telecopier No.: (713) 758-2346
If to the Stockholders:
John A. Elorriaga
Dr. Brian Bussanich
Frank Jungers
c/o Michael MacArthur-Phillips
Garvey, Schubert & Bauer
Eleventh Floor
121 S.W. Morrison Street
Portland, Oregon 97204-3141
Telecopier No: (503) 226-0259
or to such other address or telecopier number as any party
may, from time to time, designate in a written notice given in
a like manner. Notice given by telecopier shall be deemed
delivered on the day the sender receives telecopier
confirmation that such notice was received at the telecopier
number of the addressee. Notice given by mail as set out
above shall be deemed delivered three days after the date the
same is postmarked.
<PAGE>
(d) From and after the termination of this Agreement,
the covenants of the parties set forth herein shall be of no
further force or effect and the parties shall be under no
further obligation with respect thereto.
(e) DEFINITIONS. For purposes of this Agreement, the
following terms shall have the following meanings:
(i) AFFILIATE. "Affiliate" shall have the
meaning ascribed to it in Rule 12b-2 of the General
Rules and Regulations under the Exchange Act, as in
effect on the date hereof.
(ii) BENEFICIAL OWNER. A person shall
be deemed a "beneficial owner" of or to have "beneficial
ownership" Company Shares in accordance with the
interpretation of the term "beneficial ownership" as defined
in Rule 13-d(3) under the Exchange Act, as in effect on the
date hereof, provided that a person shall be deemed to be the
beneficial owner of, and to have beneficial ownership of,
Company Shares that such person or any Affiliate of such
person has the right to acquire (whether such right is
exercisable immediately or only after the passage of time)
pursuant to any agreement, arrangement or understanding or
upon the exercise of conversion rights, exchange rights,
warrant or options, or otherwise.
(iii) MERGER. "Merger" shall mean the
transaction referred to in the second whereas clause of
this Agreement, or any amendment to or modification does
not reduce the value of the financial consideration to
be received by Stockholders pursuant to the transaction
set forth in the Merger Agreement.
(iv) PERSON. A "person" shall mean any
individual, firm, corporation, partnership, trust, limited
liability company or other entity.
(v) SIGNIFICANT SUBSIDIARY. "Significant
Subsidiary" shall have the meaning ascribed to it in Rule
1-02 of SEC Regulation S-X as in effect on the date hereof.
(g) DUE AUTHORIZATION, NO CONFLICTS.
The Stockholders hereby represent and warrant to Acquiror as
follows: the Stockholders have full power and authority to
enter into this Agreement. Neither the execution or delivery
of this Agreement nor the consummation of the transactions
contemplated herein will (a) conflict with or result in a
breach, default or violation of (i) any of the terms,
provisions or conditions of the Certificate of Incorporation
or Bylaws of any member of the Stockholder Group or (ii) any
agreement, proxy, document, instrument, judgment, decree,
order, governmental permit, certificate, license, law,
statute, rule or regulation to which any member of the
Stockholder Group is a party or to which it is subject, (b)
result in the creation of any lien, charge or other
encumbrance on any shares of Company Common Stock or (c)
require any member of the Stockholder Group to obtain the
consent of any private nongovernmental third party. No
consent, action, approval or authorization of, or
registration, declaration or filing with, any governmental
department, commission, agency or other instrumentality or any
other person or entity is required to
<PAGE>
authorize, or is otherwise required in connection with, the
execution and delivery of this Agreement or any Stockholder's
performance of the terms of this Agreement or the validity or
enforceability of this Agreement.
(h) SUCCESSORS AND ASSIGNS. This Agreement shall be
binding upon, and inure to the benefit of, the parties hereto
and their respective heirs, personal representatives, successors,
assigns and Affiliates, but shall not be assignable by any party
hereto without the prior written consent of the other parties hereto.
(i) WAIVER. No party may waive any of the terms or
conditions of this Agreement except by a duly signed writing
referring to the specific provision to be waived.
(j) GOVERNING LAW. This Agreement shall be governed
by, and construed and enforced in accordance with, the laws
of the State of Delaware.
(k) ENTIRE AGREEMENT. This Agreement constitutes the
entire agreement, and supersedes all other and prior agreements
and understandings, both written and oral, among the parties hereto
and their Affiliates.
(1) COUNTERPARTS. This Agreement may be executed in
two or more counterparts, each of which shall be deemed an
original but all of which shall constitute one and the same
instrument.
IN WITNESS WHEREOF, the undersigned have executed this
Agreement on the day and month first written above.
HORIZON/CMS HEALTHCARE CORPORATION
By: /s/ Charles H. Gonzales
----------------------------------------
Its: Senior Vice President of Subsidiary
----------------------------------------
Operations
STOCKHOLDERS:
/s/ Brian Bussanich
----------------------------------------
/s/ John A. Elorriaga
----------------------------------------
/s/ Frank Jungers
----------------------------------------
<PAGE>
EXHIBIT 99
November 10, 1995
NEWS RELEASE
For Immediate Release
CONTACT:
- --------
Horizon/CMS Healthcare Corporation Pacific Rehabilitation &
Michael H. Seeliger Sports Medicine, Inc.
Vice President of Investor and William A. Norris
Corporation Relations Executive Vice President-Finance
(505) 881-4961 & Administration
(360) 260-8130
HORIZON/CMS HEALTHCARE CORPORATION TO ACQUIRE
PACIFIC REHABILITATION & SPORTS MEDICINE, INC.
IN STOCK MERGER
ALBUQUERQUE, NEW MEXICO AND VANCOUVER, WASHINGTON -- Horizon/CMS
Healthcare Corporation ("Horizon/CMS") (NYSE-HHC) and Pacific Rehabilitation
& Sports Medicine, Inc. ("Pacific Rehab") (NASDAQ:PRHB) jointly announced
today that Horizon/CMS has agreed to acquire Pacific Rehab pursuant to a
merger agreement unanimously approved by each company's Board of Directors.
Under the terms of the agreement, Pacific Rehab stockholders will
receive .3483 shares of Horizon/CMS common stock for each share of Pacific
Rehab common stock. Horizon/CMS will issue approximately 2.787 million shares
of common stock or 5.5% of outstanding shares. This transaction is intended
to be tax free to Pacific Rehab stockholders and to be accounted for as a
pooling of interests. The aggregate price of the transaction is approximately
$62 million.
Commenting on the acquisition, Horizon/CMS Healthcare Corporation's
Chairman and
______________________________________________________________________________
<PAGE>
Horizon/CMS has the option to purchase up to 15% of the outstanding common
stock of Pacific Rehab at $7.73 per share under certain specified
circumstances. Finally, Pacific Rehab's principal insider shareholders have
entered into an agreement with Horizon/CMS pursuant to which these
individuals have agreed to vote the Pacific Rehab shares owned or controlled
by them in favor of the merger. Their shares constitute approximately 11% of
the outstanding shares of Pacific Rehab.
Pacific Rehab provides outpatient physical therapy services at 72
outpatient rehabilitation clinics in ten states. Pacific Rehab's annualized
revenues based on the quarter ended September 30, 1995, were approximately
$40 million.
Smith Barney Inc. has acted as financial advisor to Pacific Rehab in
connection with the proposed transaction.
Horizon/CMS is one of the nation's largest diversified health care
providers of acute rehabilitation services, subacute and long-term nursing
care and contract therapy services. Additionally, the Company provides an
extensive array of specialty health care services including pharmacy,
rehabilitation therapies, clinical laboratory and physician placement and
practice management services as well as medical and sleep diagnostic
services, home respiratory care and Alzheimer's care. Horizon/CMS operates
thirty-seven acute rehabilitation hospitals and 134 long-term care centers
totaling 17,897 beds. Horizon/CMS also provides subacute care through 55
specialty hospitals and specialty subacute units; and outpatient
rehabilitation services at more than 140 locations. In addition, the Company
provides contract therapy services in 34 states and institutional pharmacy
services in 17 states.
3
